{
  "search_results": {
    "$": {
      "count": "3874"
    },
    "query": [
      "cardiovascular+disease | First posted from 01/01/2015 to 12/31/2016"
    ],
    "study": [
      {
        "$": {
          "rank": "1"
        },
        "nct_id": [
          "NCT02743533"
        ],
        "title": [
          "Cardiovascular Diseases in the Silesian Region in Poland."
        ],
        "acronym": [
          "SILICARD"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Number of participants with reported deaths from any cause",
              "Trends in the number of hospitalization due to cardiovascular diseases",
              "Trends in the number of diagnostic and therapeutic procedures",
              "Number of participants with reported rehospitalization"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Silesian Centre for Heart Diseases"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "10000000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "SCD016"
            ]
          }
        ],
        "start_date": [
          "January 2006"
        ],
        "primary_completion_date": [
          "December 2020"
        ],
        "completion_date": [
          "December 2021"
        ],
        "last_verified": [
          "April 2017"
        ],
        "first_received": [
          "April 4, 2016"
        ],
        "last_updated": [
          "April 24, 2017"
        ],
        "study_first_submitted": [
          "April 4, 2016"
        ],
        "study_first_posted": [
          "April 19, 2016"
        ],
        "last_update_submitted": [
          "April 24, 2017"
        ],
        "last_update_posted": [
          "April 25, 2017"
        ],
        "locations": [
          {
            "location": [
              "Silesian Center for Heart Diseases, Zabrze, Poland"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02743533"
        ]
      },
      {
        "$": {
          "rank": "2"
        },
        "nct_id": [
          "NCT02707432"
        ],
        "title": [
          "Reducing Cardiovascular Disease Risk Factors in Rural Communities in North Carolina"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Heart Matters",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Weight",
              "Self reported acceptability of the program",
              "Change in percentage of participants with controlled blood pressure, from baseline to 6 months"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of North Carolina, Chapel Hill"
            ],
            "collaborator": [
              "National Heart, Lung, and Blood Institute (NHLBI)",
              "James McFarlin Community Development, Inc.",
              "Project Momentum, Inc."
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "21 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "150"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "NIH",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Participant)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "13-2576",
              "5R01HL120690-02"
            ]
          }
        ],
        "start_date": [
          "March 27, 2017"
        ],
        "primary_completion_date": [
          "November 2018"
        ],
        "completion_date": [
          "May 2019"
        ],
        "last_verified": [
          "April 2017"
        ],
        "first_received": [
          "March 9, 2016"
        ],
        "last_updated": [
          "July 31, 2017"
        ],
        "study_first_submitted": [
          "March 9, 2016"
        ],
        "study_first_posted": [
          "March 14, 2016"
        ],
        "last_update_submitted": [
          "July 31, 2017"
        ],
        "last_update_posted": [
          "August 1, 2017"
        ],
        "locations": [
          {
            "location": [
              "Project Momentum Inc., Rocky Mount, North Carolina, United States",
              "Shirley McFarlin, Rocky Mount, North Carolina, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02707432"
        ]
      },
      {
        "$": {
          "rank": "3"
        },
        "nct_id": [
          "NCT02430025"
        ],
        "title": [
          "Fujian Province Cardiovascular Diseases Study"
        ],
        "acronym": [
          "FJCVD"
        ],
        "recruitment": [
          {
            "_": "Not yet recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "To further find some unknown small Metabolic molecules by mass spectrometry"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Fujian Provincial Hospital"
            ],
            "collaborator": [
              "Peking University"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "8000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "FJPH20150101"
            ]
          }
        ],
        "start_date": [
          "June 2015"
        ],
        "primary_completion_date": [
          "May 2020"
        ],
        "completion_date": [
          "May 2020"
        ],
        "last_verified": [
          "April 2015"
        ],
        "first_received": [
          "April 23, 2015"
        ],
        "last_updated": [
          "April 28, 2015"
        ],
        "study_first_submitted": [
          "April 23, 2015"
        ],
        "study_first_posted": [
          "April 29, 2015"
        ],
        "last_update_submitted": [
          "April 28, 2015"
        ],
        "last_update_posted": [
          "April 29, 2015"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02430025"
        ]
      },
      {
        "$": {
          "rank": "4"
        },
        "nct_id": [
          "NCT02641834"
        ],
        "title": [
          "Prevention of Cardiovascular Disease With Med or Veg Diets"
        ],
        "acronym": [
          "CARDIVEG"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Vegetarian diet",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Mediterranean diet",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Weight change",
              "Total fat mass change"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Azienda Ospedaliero-Universitaria Careggi"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "75 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "100"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "CAR-123-VEG"
            ]
          }
        ],
        "start_date": [
          "January 2016"
        ],
        "primary_completion_date": [
          "July 2016"
        ],
        "completion_date": [
          "December 2016"
        ],
        "last_verified": [
          "December 2016"
        ],
        "first_received": [
          "December 22, 2015"
        ],
        "last_updated": [
          "December 14, 2016"
        ],
        "study_first_submitted": [
          "December 22, 2015"
        ],
        "study_first_posted": [
          "December 30, 2015"
        ],
        "last_update_submitted": [
          "December 14, 2016"
        ],
        "last_update_posted": [
          "December 15, 2016"
        ],
        "locations": [
          {
            "location": [
              "Unit of Clinical Nutrition, University Hospital of Careggi, Florence, Italy"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02641834"
        ]
      },
      {
        "$": {
          "rank": "5"
        },
        "nct_id": [
          "NCT02347982"
        ],
        "title": [
          "Epidemiology of Cardiovascular Disease in Elderly Turkish Population"
        ],
        "acronym": [
          "ELDER-TURK"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "To generate a national database for cardiovascular diseases for elderly patients in Turkey"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Turkish Society of Cardiology"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "2500"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Cross-Sectional"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "ELDER-TURK"
            ]
          }
        ],
        "start_date": [
          "June 2015"
        ],
        "primary_completion_date": [
          "December 2015"
        ],
        "completion_date": [
          "December 2015"
        ],
        "last_verified": [
          "April 2016"
        ],
        "first_received": [
          "January 20, 2015"
        ],
        "last_updated": [
          "April 20, 2016"
        ],
        "study_first_submitted": [
          "January 20, 2015"
        ],
        "study_first_posted": [
          "January 28, 2015"
        ],
        "last_update_submitted": [
          "April 20, 2016"
        ],
        "last_update_posted": [
          "April 21, 2016"
        ],
        "locations": [
          {
            "location": [
              "Ege University Faculty of Medicine, Izmir, Turkey"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02347982"
        ]
      },
      {
        "$": {
          "rank": "6"
        },
        "nct_id": [
          "NCT02735486"
        ],
        "title": [
          "Acute Effects of Ginger Extract Consumption on Risk Markers of Cardiovascular Disease"
        ],
        "acronym": [
          "G-CVD"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Ginger drink",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Placebo: Super pure water",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Reduction in blood pressure (BP)",
              "Flow mediated dilatation"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Reading"
            ]
          }
        ],
        "gender": [
          "Male"
        ],
        "min_age": [
          "30 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "22"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Single (Participant)",
              "Primary Purpose: Basic Science"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "PHYTOVAS II"
            ]
          }
        ],
        "start_date": [
          "February 2014"
        ],
        "primary_completion_date": [
          "August 2014"
        ],
        "completion_date": [
          "August 2014"
        ],
        "last_verified": [
          "April 2016"
        ],
        "first_received": [
          "December 8, 2015"
        ],
        "last_updated": [
          "April 6, 2016"
        ],
        "study_first_submitted": [
          "December 8, 2015"
        ],
        "study_first_posted": [
          "April 12, 2016"
        ],
        "last_update_submitted": [
          "April 6, 2016"
        ],
        "last_update_posted": [
          "April 12, 2016"
        ],
        "locations": [
          {
            "location": [
              "Department of Food and Nutritional Sciences, Reading, Berkshire, United Kingdom"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02735486"
        ]
      },
      {
        "$": {
          "rank": "7"
        },
        "nct_id": [
          "NCT02777515"
        ],
        "title": [
          "Study of the Immediate Cardiovascular Effects of Electronic Cigarette in Subjects With Cardiovascular Disease"
        ],
        "acronym": [
          "ECLOP"
        ],
        "recruitment": [
          {
            "_": "Terminated",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "CARDIOVASCULAR DISEASES"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "uses of electronic cigarette",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Assessment of change of blood pressure",
              "Assessment of change of Electrocardiogram (ECG)",
              "Assessment of change of Holter-ECG",
              "Assessment of change of transthoracic echocardiogram"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Groupe Hospitalier Paris Saint Joseph"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "35 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "5"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Device Feasibility"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "ECLOP"
            ]
          }
        ],
        "start_date": [
          "May 4, 2015"
        ],
        "primary_completion_date": [
          "December 5, 2015"
        ],
        "completion_date": [
          "December 31, 2015"
        ],
        "last_verified": [
          "February 2017"
        ],
        "first_received": [
          "May 9, 2016"
        ],
        "last_updated": [
          "September 4, 2017"
        ],
        "study_first_submitted": [
          "May 9, 2016"
        ],
        "study_first_posted": [
          "May 19, 2016"
        ],
        "last_update_submitted": [
          "September 4, 2017"
        ],
        "last_update_posted": [
          "September 6, 2017"
        ],
        "locations": [
          {
            "location": [
              "Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02777515"
        ]
      },
      {
        "$": {
          "rank": "8"
        },
        "nct_id": [
          "NCT02486913"
        ],
        "title": [
          "Enhancing Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Enhanced Health Check",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in Heart Age",
              "Changes in smoking status",
              "Change in total cholesterol",
              "Change in systolic blood pressure",
              "Change in body mass index"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Queen Mary University of London"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "74 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "110"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Non-Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "MCPH1C8R"
            ]
          }
        ],
        "start_date": [
          "August 2015"
        ],
        "primary_completion_date": [
          "December 2017"
        ],
        "completion_date": [
          "March 2018"
        ],
        "last_verified": [
          "February 2017"
        ],
        "first_received": [
          "June 16, 2015"
        ],
        "last_updated": [
          "February 27, 2017"
        ],
        "study_first_submitted": [
          "June 16, 2015"
        ],
        "study_first_posted": [
          "July 1, 2015"
        ],
        "last_update_submitted": [
          "February 27, 2017"
        ],
        "last_update_posted": [
          "February 28, 2017"
        ],
        "locations": [
          {
            "location": [
              "Bart's Heart Centre, London, United Kingdom"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02486913"
        ]
      },
      {
        "$": {
          "rank": "9"
        },
        "nct_id": [
          "NCT02479269"
        ],
        "title": [
          "The Influence of Aerobic Exercise on Serum Brain Natriuretic Peptide and C- Reactive Protein in Cardiovascular Disease"
        ],
        "acronym": [
          "AEBNPCRP"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Aerobic exercise",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Brain Natriuretic Peptide",
              "serum C - reactive protein",
              "serum lipoproteins",
              "Body Mass Index",
              "blood pressure"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Shiraz University of Medical Sciences"
            ],
            "collaborator": [
              "Islamic Azad University, Shiraz"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "60"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "CT-P-92-6517"
            ]
          }
        ],
        "start_date": [
          "March 2015"
        ],
        "primary_completion_date": [
          "May 2015"
        ],
        "completion_date": [
          "May 2015"
        ],
        "last_verified": [
          "May 2016"
        ],
        "first_received": [
          "June 13, 2015"
        ],
        "last_updated": [
          "May 8, 2016"
        ],
        "study_first_submitted": [
          "June 13, 2015"
        ],
        "study_first_posted": [
          "June 24, 2015"
        ],
        "last_update_submitted": [
          "May 8, 2016"
        ],
        "last_update_posted": [
          "May 10, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02479269"
        ]
      },
      {
        "$": {
          "rank": "10"
        },
        "nct_id": [
          "NCT02514564"
        ],
        "title": [
          "The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Exercise",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Changes in Skin microvascular blood flow",
              "Change in peak oxygen consumption",
              "Change in weight"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Instituto Nacional de Cardiologia de Laranjeiras"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "80 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "115"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "Faperj-E-26/101.575"
            ]
          }
        ],
        "start_date": [
          "December 2014"
        ],
        "primary_completion_date": [
          "December 2016"
        ],
        "completion_date": [
          "December 2016"
        ],
        "last_verified": [
          "March 2017"
        ],
        "first_received": [
          "July 30, 2015"
        ],
        "last_updated": [
          "March 1, 2017"
        ],
        "study_first_submitted": [
          "July 30, 2015"
        ],
        "study_first_posted": [
          "August 3, 2015"
        ],
        "last_update_submitted": [
          "March 1, 2017"
        ],
        "last_update_posted": [
          "March 3, 2017"
        ],
        "locations": [
          {
            "location": [
              "Instituto Nacional de Cardiologia, Rio de Janeiro, RJ, Brazil"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02514564"
        ]
      },
      {
        "$": {
          "rank": "11"
        },
        "nct_id": [
          "NCT02350192"
        ],
        "title": [
          "Effectiveness of an E-health Educational Intervention for Cardiovascular Disease Adults in Improving Outcomes"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "e-health educational intervention (eHEI)",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Changes in total physical exercise (measured by The Godin-Shephard Leisure-Time Physical Activity Questionnaire)",
              "Changes in exercise efficacy (measured by a validated scale. The scale consists of 9 items and responses are made on a 0-10 scale)",
              "Exercise adherence (two simple questions will be asked: how often do you do any physical activity per week? and What is the duration of the exercise on average?)",
              "Changes in anxiety and depression (Chinese version of the Hospital anxiety and depression scale)",
              "Changes in quality of Life (Chinese version of the health survey questionnaire (SF-12)",
              "Cardiac risk factor profile (Demographic data will be collected through questionnaire)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Chinese University of Hong Kong"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "30 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "438"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Investigator)",
              "Primary Purpose: Supportive Care"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "10110301"
            ]
          }
        ],
        "start_date": [
          "June 2013"
        ],
        "primary_completion_date": [
          "July 2015"
        ],
        "completion_date": [
          "July 2015"
        ],
        "last_verified": [
          "July 2016"
        ],
        "first_received": [
          "January 21, 2015"
        ],
        "last_updated": [
          "July 26, 2016"
        ],
        "study_first_submitted": [
          "January 21, 2015"
        ],
        "study_first_posted": [
          "January 29, 2015"
        ],
        "last_update_submitted": [
          "July 26, 2016"
        ],
        "last_update_posted": [
          "July 27, 2016"
        ],
        "locations": [
          {
            "location": [
              "Tung Wah Eastern Hospital, Causeway Bay, Hong Kong Island, Hong Kong",
              "Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong Island, Hong Kong"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02350192"
        ]
      },
      {
        "$": {
          "rank": "12"
        },
        "nct_id": [
          "NCT02837471"
        ],
        "title": [
          "Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking Canadians"
        ],
        "acronym": [
          "PiezoRx"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "PiezoRx medical grade pedometer",
                "$": {
                  "type": "Device"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in number of participants who use the PiezoRx device",
              "Change in frequency of using the PiezoRx device",
              "Changes in moderate to vigorous physical activity time",
              "Number of participants that continue wearing the PiezoRx device beyond the 3 month intervention",
              "Validation of Physical activity questionnaire",
              "Analysis of physical activity data (hrs/min) recorded by PiezoRx device and ActiGraph accelerometer and comparing the values.",
              "Changes in blood pressure",
              "Changes in blood lipids",
              "Changes in fasting glycosylated hemoglobin",
              "Changes in body weight",
              "Changes in body mass index",
              "Changes in waist circumference",
              "Changes in resting heart rate",
              "Changes in anxiety and depression"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Ottawa Heart Institute Research Corporation"
            ],
            "collaborator": [
              "StepsCount Inc"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "120"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Double (Care Provider, Investigator)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "20160491"
            ]
          }
        ],
        "start_date": [
          "October 2016"
        ],
        "primary_completion_date": [
          "March 2018"
        ],
        "completion_date": [
          "August 2018"
        ],
        "last_verified": [
          "October 2016"
        ],
        "first_received": [
          "July 1, 2016"
        ],
        "last_updated": [
          "April 12, 2017"
        ],
        "study_first_submitted": [
          "July 1, 2016"
        ],
        "study_first_posted": [
          "July 19, 2016"
        ],
        "last_update_submitted": [
          "April 12, 2017"
        ],
        "last_update_posted": [
          "April 13, 2017"
        ],
        "locations": [
          {
            "location": [
              "University of Ottawa Heart Insititue, Ottawa, Ontario, Canada",
              "University of Ottawa Heart Institute, Ottawa, Ontario, Canada"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02837471"
        ]
      },
      {
        "$": {
          "rank": "13"
        },
        "nct_id": [
          "NCT03004638"
        ],
        "title": [
          "Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Atherosclerosis",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "MEDI6012",
                "$": {
                  "type": "Biological"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Biological"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Number of subjects with adverse events and serious adverse events as a measure of safety and tolerability of MEDI6012",
              "Number of MEDI6012 subjects with treatment-emergent AEs related to 12-lead ECG",
              "Number of MEDI6012 subjects with treatment-emergent AEs related to vital signs",
              "Number of MEDI6012 subjects with treatment-emergent AEs related to laboratory results",
              "Baseline adjusted area under the curve",
              "Pharmacokinetics of MEDI6012 Cmax",
              "Immunogenicity rate",
              "Pharmacokinetics of MEDI6012 Tmax",
              "Pharmacokinetics of MEDI6012 AUC",
              "Pharmacokinetics of MEDI6012 Terminal Half life"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "MedImmune LLC"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "60 Years"
        ],
        "max_age": [
          "80 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 2"
            ]
          }
        ],
        "enrollment": [
          "32"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "D5780C00005"
            ]
          }
        ],
        "start_date": [
          "January 23, 2017"
        ],
        "primary_completion_date": [
          "November 14, 2017"
        ],
        "completion_date": [
          "November 14, 2017"
        ],
        "last_verified": [
          "August 2017"
        ],
        "first_received": [
          "December 12, 2016"
        ],
        "last_updated": [
          "August 14, 2017"
        ],
        "study_first_submitted": [
          "December 12, 2016"
        ],
        "study_first_posted": [
          "December 29, 2016"
        ],
        "last_update_submitted": [
          "August 14, 2017"
        ],
        "last_update_posted": [
          "August 17, 2017"
        ],
        "locations": [
          {
            "location": [
              "Research Site, Anniston, Alabama, United States",
              "Research Site, Jacksonville, Florida, United States",
              "Research Site, Port Orange, Florida, United States",
              "Research Site, Cincinnati, Ohio, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT03004638"
        ]
      },
      {
        "$": {
          "rank": "14"
        },
        "nct_id": [
          "NCT02570035"
        ],
        "title": [
          "Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Overactive Bladder",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Mirabegron",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Changes in electrocardiogram parameters pre- and post- administration of mirabegron",
              "Incidence rate of cardiovascular system adverse reactions",
              "Safety assessed by biochemistry laboratory tests",
              "Safety assessed by incidence of adverse events",
              "Changes in overactive bladder (OAB) symptoms"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Astellas Pharma Inc"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "316"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "BE0003"
            ]
          }
        ],
        "start_date": [
          "December 2012"
        ],
        "primary_completion_date": [
          "March 2015"
        ],
        "completion_date": [
          "March 2015"
        ],
        "last_verified": [
          "October 2015"
        ],
        "first_received": [
          "October 6, 2015"
        ],
        "last_updated": [
          "October 6, 2015"
        ],
        "study_first_submitted": [
          "October 6, 2015"
        ],
        "study_first_posted": [
          "October 7, 2015"
        ],
        "last_update_submitted": [
          "October 6, 2015"
        ],
        "last_update_posted": [
          "October 7, 2015"
        ],
        "locations": [
          {
            "location": [
              "Site JP81013, Aichi, Japan",
              "Site JP81014, Aichi, Japan",
              "Site JP81005, Chiba, Japan",
              "Site JP81006, Chiba, Japan",
              "Site JP81007, Chiba, Japan",
              "Site JP81026, Fukuoka, Japan",
              "Site JP81027, Fukuoka, Japan",
              "Site JP81001, Hokkaido, Japan",
              "Site JP81002, Hokkaido, Japan",
              "Site JP81021, Hyogo, Japan",
              "Site JP81022, Hyogo, Japan",
              "Site JP81023, Hyogo, Japan",
              "Site JP81024, Hyogo, Japan",
              "Site JP81025, Hyogo, Japan",
              "Site JP81028, Kagoshima, Japan",
              "Site JP81011, Kanagawa, Japan",
              "Site JP81012, Kanagawa, Japan",
              "Site JP81003, Niigata, Japan",
              "Site JP81016, Osaka, Japan",
              "Site JP81017, Osaka, Japan",
              "Site JP81018, Osaka, Japan",
              "Site JP81019, Osaka, Japan",
              "Site JP81020, Osaka, Japan",
              "Site JP81004, Saitama, Japan",
              "Site JP81015, Shizuoka, Japan",
              "Site JP81008, Tokyo, Japan",
              "Site JP81009, Tokyo, Japan",
              "Site JP81010, Tokyo, Japan"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02570035"
        ]
      },
      {
        "$": {
          "rank": "15"
        },
        "nct_id": [
          "NCT02513017"
        ],
        "title": [
          "Insomnia and Cardiovascular Diseases: Influence of Behavioral Treatments and Preferences"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Insomnia",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Stimulus Control Instructions and Sleep Restriction Therapy",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Sleep Outcome Sleep Quantity Change over time",
              "Sleep Outcome: Sleep Quality change over time",
              "Psychological Outcomes: Anxiety change over time",
              "Psychological Outcomes: Depression change over time",
              "Physical Outcomes: Cardiovascular Symptoms and Events Change over time"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Ryerson University"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "204"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Factorial Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "PCR - 101411"
            ]
          }
        ],
        "start_date": [
          "February 2009"
        ],
        "primary_completion_date": [
          "March 2013"
        ],
        "completion_date": [
          "March 2013"
        ],
        "last_verified": [
          "July 2015"
        ],
        "first_received": [
          "July 22, 2015"
        ],
        "last_updated": [
          "July 30, 2015"
        ],
        "study_first_submitted": [
          "July 22, 2015"
        ],
        "study_first_posted": [
          "July 31, 2015"
        ],
        "last_update_submitted": [
          "July 30, 2015"
        ],
        "last_update_posted": [
          "July 31, 2015"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02513017"
        ]
      },
      {
        "$": {
          "rank": "16"
        },
        "nct_id": [
          "NCT02370680"
        ],
        "title": [
          "Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease"
        ],
        "acronym": [
          "DURATION"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Aspirin",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Durlaza™",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "change in platelet aggregation",
              "Reactive Hyperemia Index",
              "Safety as measured by the number and system class of adverse events reported in each treatment arm"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "New Haven Pharmaceuticals, Inc."
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 1"
            ]
          }
        ],
        "enrollment": [
          "41"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Non-Randomized",
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Basic Science"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "NHP-ASP-102"
            ]
          }
        ],
        "start_date": [
          "February 2015"
        ],
        "primary_completion_date": [
          "July 2015"
        ],
        "completion_date": [
          "July 2015"
        ],
        "last_verified": [
          "August 2015"
        ],
        "first_received": [
          "February 11, 2015"
        ],
        "last_updated": [
          "August 4, 2015"
        ],
        "study_first_submitted": [
          "February 11, 2015"
        ],
        "study_first_posted": [
          "February 25, 2015"
        ],
        "last_update_submitted": [
          "August 4, 2015"
        ],
        "last_update_posted": [
          "August 6, 2015"
        ],
        "locations": [
          {
            "location": [
              "Platelet and Thrombosis Research, LLC, Baltimore, Maryland, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02370680"
        ]
      },
      {
        "$": {
          "rank": "17"
        },
        "nct_id": [
          "NCT02388542"
        ],
        "title": [
          "Effect of Peer-mentor Mediated Interventions on Cardiovascular Risk Factors at Worksites"
        ],
        "acronym": [
          "PROGRESS"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Educational Intervention",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in knowledge attitudes & practices related to Cardiovascular risk factors. (questionnaire)",
              "Identification of barriers and facilitators for an optimal Cardiovascular Health environment. (In depth interviews and focus groups discussions with random sample of participants)",
              "Estimate the Cardiovascular risk factor burden (validated non lab based Cardiovascular risk score)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "St. John's Research Institute"
            ],
            "collaborator": [
              "International Centre for Diarrhoeal Disease Research, Bangladesh",
              "University of Colombo",
              "University of Oxford"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "35 Years"
        ],
        "max_age": [
          "70 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "334"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "PROGRESS-IND-1022015"
            ]
          }
        ],
        "start_date": [
          "May 2015"
        ],
        "primary_completion_date": [
          "October 2017"
        ],
        "completion_date": [
          "December 2017"
        ],
        "last_verified": [
          "October 2016"
        ],
        "first_received": [
          "February 9, 2015"
        ],
        "last_updated": [
          "September 13, 2017"
        ],
        "study_first_submitted": [
          "February 9, 2015"
        ],
        "study_first_posted": [
          "March 17, 2015"
        ],
        "last_update_submitted": [
          "September 13, 2017"
        ],
        "last_update_posted": [
          "September 14, 2017"
        ],
        "locations": [
          {
            "location": [
              "Appollo Ispat Complex Ltd, Dhaka, Bangladesh",
              "Shardharan Bima Coorporation, Dhaka, Bangladesh",
              "Bharat Heavy Electrical Limited, Bangalore, India",
              "TVS Motor company Limited, Hosur, India",
              "Department of Census & Statistics, Colombo, Sri Lanka",
              "Sri Lanka Telecom, Colombo, Sri Lanka"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02388542"
        ]
      },
      {
        "$": {
          "rank": "18"
        },
        "nct_id": [
          "NCT02473705"
        ],
        "title": [
          "Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease"
        ],
        "acronym": [
          "CKD&CAD"
        ],
        "recruitment": [
          {
            "_": "Withdrawn",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Chronic Kidney Disease",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Fish Oil and Bicarbonate",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Fish Oil and Bicarbonate Placebo",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Fish Oil Placebo and Bicarbonate",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Fish Oil Placebo and Bicarbonate Placebo",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change from Baseline of VO2 peak at 12 weeks"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Wake Forest University Health Sciences"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "60 Years"
        ],
        "max_age": [
          "90 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "0"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Factorial Assignment",
              "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "WakeForest"
            ]
          }
        ],
        "start_date": [
          "January 2016"
        ],
        "primary_completion_date": [
          "June 2017"
        ],
        "completion_date": [
          "June 2017"
        ],
        "last_verified": [
          "September 2016"
        ],
        "first_received": [
          "June 10, 2015"
        ],
        "last_updated": [
          "September 7, 2016"
        ],
        "study_first_submitted": [
          "June 10, 2015"
        ],
        "study_first_posted": [
          "June 16, 2015"
        ],
        "last_update_submitted": [
          "September 7, 2016"
        ],
        "last_update_posted": [
          "September 9, 2016"
        ],
        "locations": [
          {
            "location": [
              "Wake Forest Baptist Health Cardiac Rehab, Winston Salem, North Carolina, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02473705"
        ]
      },
      {
        "$": {
          "rank": "19"
        },
        "nct_id": [
          "NCT02388971"
        ],
        "title": [
          "Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Withdrawn",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Atherosclerotic Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "MLN1202",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "The change in arterial FDG uptake from MLN1202 treatment relative to placebo, comparing pretreatment and 3 month post-treatment time points",
              "The change in arterial FDG uptake from MLN1202 treatment relative to placebo, comparing pretreatment and 3 month post-treatment time points in subjects identified using a dominant model of the snip in the MCP-1 polymorphisms [MCP-1 -2518 (rs1024611)].",
              "Change from Baseline in Mean Carotid Vessel MDS TBR",
              "Change from Baseline in Mean Active Segment TBR",
              "Change from Baseline in Mean Index Vessel TBR",
              "Change from Baseline in Mean Carotid Vessel TBR"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Takeda"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "35 Years"
        ],
        "max_age": [
          "80 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 2"
            ]
          }
        ],
        "enrollment": [
          "0"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Triple (Participant, Care Provider, Investigator)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "MLN1202-2006",
              "U1111-1159-5742"
            ]
          }
        ],
        "start_date": [
          "April 2016"
        ],
        "primary_completion_date": [
          "April 2016"
        ],
        "completion_date": [
          "April 2016"
        ],
        "last_verified": [
          "December 2015"
        ],
        "first_received": [
          "February 23, 2015"
        ],
        "last_updated": [
          "December 8, 2015"
        ],
        "study_first_submitted": [
          "February 23, 2015"
        ],
        "study_first_posted": [
          "March 17, 2015"
        ],
        "last_update_submitted": [
          "December 8, 2015"
        ],
        "last_update_posted": [
          "December 10, 2015"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02388971"
        ]
      },
      {
        "$": {
          "rank": "20"
        },
        "nct_id": [
          "NCT02863211"
        ],
        "title": [
          "The Assessment of Large and Small Artery Elasticity for the Early Detection of Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases",
              "Vascular Stiffness"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Ischemic heart disease",
              "Acute myocardial infarction",
              "Stroke",
              "Percutaneous coronary intervention",
              "Coronary artery bypass surgery",
              "Congestive heart failure",
              "Hypertension"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "St. Boniface General Hospital Research Centre"
            ]
          }
        ],
        "gender": [
          "Female"
        ],
        "min_age": [
          "55 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "1000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "H2014:224"
            ]
          }
        ],
        "start_date": [
          "September 2015"
        ],
        "primary_completion_date": [
          "February 2022"
        ],
        "completion_date": [
          "February 2022"
        ],
        "last_verified": [
          "January 2017"
        ],
        "first_received": [
          "August 8, 2016"
        ],
        "last_updated": [
          "January 30, 2017"
        ],
        "study_first_submitted": [
          "August 8, 2016"
        ],
        "study_first_posted": [
          "August 11, 2016"
        ],
        "last_update_submitted": [
          "January 30, 2017"
        ],
        "last_update_posted": [
          "February 1, 2017"
        ],
        "locations": [
          {
            "location": [
              "St-Boniface Hospital Albrechtsen Research Center, Winnipeg, Manitoba, Canada"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02863211"
        ]
      },
      {
        "$": {
          "rank": "21"
        },
        "nct_id": [
          "NCT02677467"
        ],
        "title": [
          "Correlation Between Epistaxis and Cardiovascular Disease"
        ],
        "acronym": [
          "CBECD"
        ],
        "recruitment": [
          {
            "_": "Not yet recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Epistaxis"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Blood-pressure variability",
                "$": {
                  "type": "Biological"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Cholesterol level in each group",
              "BP variability level in each group",
              "Pulse wave velocity in each group",
              "Smoking History in each group",
              "Body Mass Index in each group"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Hanyang University"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "50"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "Gurivengers"
            ]
          }
        ],
        "start_date": [
          "March 2016"
        ],
        "primary_completion_date": [
          "June 2016"
        ],
        "completion_date": [
          "August 2016"
        ],
        "last_verified": [
          "February 2016"
        ],
        "first_received": [
          "January 31, 2016"
        ],
        "last_updated": [
          "February 8, 2016"
        ],
        "study_first_submitted": [
          "January 31, 2016"
        ],
        "study_first_posted": [
          "February 9, 2016"
        ],
        "last_update_submitted": [
          "February 8, 2016"
        ],
        "last_update_posted": [
          "February 9, 2016"
        ],
        "locations": [
          {
            "location": [
              "Hanyang University Guri Hospital, Guri-si, Gyeonggi-do, Korea, Republic of"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02677467"
        ]
      },
      {
        "$": {
          "rank": "22"
        },
        "nct_id": [
          "NCT02646488"
        ],
        "title": [
          "Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "High Blood Pressure"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Million Hearts ABCS 6 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Million Hearts ABCS 9 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Million Hearts ABCS 12 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Million Hearts ABCS 15 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Standard Care Regimen 9 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Standard Care Regimen 12 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Standard Care Regimen 15 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Standard Care Regimen 18 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Standard Care Regimen 21 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Standard Care Regimen 24 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Standard Care Regimen 27 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Follow Up Post Intervention 21 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Follow Up Post Intervention 24 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Follow Up Post Intervention 27 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Follow Up Post Intervention 30 Months",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Follow Up Post Intervention 33 Months",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Percentage of patients with documented use of aspirin or other antithrombotic.",
              "Percentage of patients who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately controlled",
              "Percentage of patients who had a fasting lipoprotein (LDL) test performed and whose risk-stratified fasting LDL is at or below the recommended low density lipoprotein (LDL) goal",
              "Change in the percentage of patients who had a low density lipoprotein (LDL) test who are prescribed a recommended dose of statin based on risk status if indicated.",
              "Percentage of patients who were screened about tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.",
              "Percentage of patients aged 18 through 85 years of age who had a diagnosis of hypertension (HTN) who are prescribed recommended medications, if indicated."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "New York University School of Medicine"
            ],
            "collaborator": [
              "Agency for Healthcare Research and Quality (AHRQ)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "85 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "250"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "U.S. Fed"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Double (Participant, Investigator)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "14-02042"
            ]
          }
        ],
        "start_date": [
          "August 2015"
        ],
        "primary_completion_date": [
          "December 2017"
        ],
        "completion_date": [
          "August 2018"
        ],
        "last_verified": [
          "October 2017"
        ],
        "first_received": [
          "December 30, 2015"
        ],
        "last_updated": [
          "October 11, 2017"
        ],
        "study_first_submitted": [
          "December 30, 2015"
        ],
        "study_first_posted": [
          "January 5, 2016"
        ],
        "last_update_submitted": [
          "October 11, 2017"
        ],
        "last_update_posted": [
          "October 12, 2017"
        ],
        "locations": [
          {
            "location": [
              "New York University School of Medicine, New York, New York, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02646488"
        ]
      },
      {
        "$": {
          "rank": "23"
        },
        "nct_id": [
          "NCT02993406"
        ],
        "title": [
          "Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo"
        ],
        "acronym": [
          "CLEAR Outcomes"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases",
              "Statin Adverse Reaction"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Bempedoic acid 180 mg tablet",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Matching placebo tablet",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Time from randomization to first occurrence of one of the following adjudicated composite endpoints: CV death, nonfatal myocardial infarction (MI), nonfatal stroke, hospitalization for unstable angina, or coronary revascularization."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Esperion Therapeutics"
            ],
            "collaborator": [
              "Cleveland Clinic Coordinating Center for Clinical Research (C5 Research)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 3"
            ]
          }
        ],
        "enrollment": [
          "12600"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Industry",
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Triple (Participant, Investigator, Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "1002-043"
            ]
          }
        ],
        "start_date": [
          "December 2016"
        ],
        "primary_completion_date": [
          "December 2021"
        ],
        "completion_date": [
          "March 2022"
        ],
        "last_verified": [
          "October 2017"
        ],
        "first_received": [
          "December 9, 2016"
        ],
        "last_updated": [
          "October 9, 2017"
        ],
        "study_first_submitted": [
          "December 9, 2016"
        ],
        "study_first_posted": [
          "December 15, 2016"
        ],
        "last_update_submitted": [
          "October 9, 2017"
        ],
        "last_update_posted": [
          "October 11, 2017"
        ],
        "locations": [
          {
            "location": [
              "Tuscumbia, Alabama, United States",
              "Pembroke Pines, Florida, United States",
              "Greensboro, North Carolina, United States",
              "Suffolk, Virginia, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02993406"
        ]
      },
      {
        "$": {
          "rank": "24"
        },
        "nct_id": [
          "NCT02336919"
        ],
        "title": [
          "The Use of Texting Messaging to Improve the Hospital-to-community Transition Period in Cardiovascular Disease Patients"
        ],
        "acronym": [
          "Txt2Prevent"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Acute Coronary Syndrome"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Txt2Prevent",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Self-management as measured by the Health Education Impact Questionnaire by Osborne et al.",
              "Medication Adherence as measured by the Morisky Medication Adherence Scale by Morisky et al.",
              "Health-related quality of life as measured by the EuroQoL 5D-5L by the EuroQoL group",
              "Hospital readmissions",
              "Mortality"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Simon Fraser University"
            ],
            "collaborator": [
              "Providence Health & Services",
              "University of British Columbia",
              "McMaster University",
              "Canadian Institutes of Health Research (CIHR)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "19 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "76"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Double (Investigator, Outcomes Assessor)",
              "Primary Purpose: Supportive Care"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "H14-02385"
            ]
          }
        ],
        "start_date": [
          "April 2015"
        ],
        "primary_completion_date": [
          "January 2017"
        ],
        "completion_date": [
          "January 2017"
        ],
        "last_verified": [
          "April 2017"
        ],
        "first_received": [
          "January 8, 2015"
        ],
        "last_updated": [
          "April 24, 2017"
        ],
        "study_first_submitted": [
          "January 8, 2015"
        ],
        "study_first_posted": [
          "January 13, 2015"
        ],
        "last_update_submitted": [
          "April 24, 2017"
        ],
        "last_update_posted": [
          "April 26, 2017"
        ],
        "locations": [
          {
            "location": [
              "St. Paul's Hospital, Vancouver, British Columbia, Canada"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02336919"
        ]
      },
      {
        "$": {
          "rank": "25"
        },
        "nct_id": [
          "NCT02433990"
        ],
        "title": [
          "Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease"
        ],
        "recruitment": [
          {
            "_": "Enrolling by invitation",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Congenital Heart Disease"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Risk factors for acquired cardiovascular disease in adults with congenital heart disease"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Stanford University"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "150"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Ecologic or Community",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "IRB-28847"
            ]
          }
        ],
        "start_date": [
          "April 2014"
        ],
        "primary_completion_date": [
          "June 1, 2017"
        ],
        "completion_date": [
          "June 1, 2017"
        ],
        "last_verified": [
          "April 2017"
        ],
        "first_received": [
          "May 13, 2014"
        ],
        "last_updated": [
          "May 9, 2017"
        ],
        "study_first_submitted": [
          "May 13, 2014"
        ],
        "study_first_posted": [
          "May 5, 2015"
        ],
        "last_update_submitted": [
          "May 9, 2017"
        ],
        "last_update_posted": [
          "May 11, 2017"
        ],
        "locations": [
          {
            "location": [
              "Stanford Hospital and Clinics, Stanford, California, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02433990"
        ]
      },
      {
        "$": {
          "rank": "26"
        },
        "nct_id": [
          "NCT02778074"
        ],
        "title": [
          "Internet-guided Cognitive Behavioural Therapy to Improve Depression Patients With Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Depression"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Internet cognitive behavioural therapy",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Moderated Discussion Forum",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Measure of change in depressive symptoms collected with the Patient Health Questionnaire-9 (PHQ-9)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University Hospital, Linkoeping"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "140"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "2015-02600"
            ]
          }
        ],
        "start_date": [
          "February 6, 2017"
        ],
        "primary_completion_date": [
          "January 2019"
        ],
        "completion_date": [
          "January 2020"
        ],
        "last_verified": [
          "February 2017"
        ],
        "first_received": [
          "May 16, 2016"
        ],
        "last_updated": [
          "February 6, 2017"
        ],
        "study_first_submitted": [
          "May 16, 2016"
        ],
        "study_first_posted": [
          "May 19, 2016"
        ],
        "last_update_submitted": [
          "February 6, 2017"
        ],
        "last_update_posted": [
          "February 8, 2017"
        ],
        "locations": [
          {
            "location": [
              "Department of Cardiology, University Hospital of Linkoping, Linköping, Sweden"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02778074"
        ]
      },
      {
        "$": {
          "rank": "27"
        },
        "nct_id": [
          "NCT02596126"
        ],
        "title": [
          "Secondary Prevention of Cardiovascular Disease in the Elderly Trial"
        ],
        "acronym": [
          "SECURE"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Myocardial Infarction",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Cardiovascular Polypill",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Treatment Prevention for Secondary CV",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Difference in the occurrence of Major Adverse Cardiovascular Events (MACE) between the Cardiovascular Combination Polypill AAR and the Standard of Care Treatment",
              "Incidence of the first occurrence of any component of the following composite endpoint: CV death, MI, stroke.",
              "Evaluate the first occurrence of the individual components of the primary endpoint",
              "Change in Treatment Adherence",
              "Change in Patient Satisfaction",
              "Change in Systolic and Diastolic Blood Pressure (SBP and DBP)",
              "Change in LDL cholesterol level",
              "Regional differences in performance of the polypill in the previous endpoints",
              "Health Economic Evaluation Comparing Intervention and Usual Care Arm",
              "Change in Quality of Life",
              "Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III"
            ],
            "collaborator": [
              "Charite University, Berlin, Germany",
              "Centre Hospitalier Universitaire de Besancon",
              "Wroclaw Medical University",
              "Semmelweis University",
              "General University Hospital, Prague",
              "Servicio Madrileño de Salud, Madrid, Spain",
              "London School of Hygiene and Tropical Medicine",
              "Ferrer Internacional S.A.",
              "Istituto Di Ricerche Farmacologiche Mario Negri"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 3"
            ]
          }
        ],
        "enrollment": [
          "3206"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "633765",
              "2015-002868-17"
            ]
          }
        ],
        "start_date": [
          "July 2016"
        ],
        "primary_completion_date": [
          "October 2019"
        ],
        "completion_date": [
          "January 2020"
        ],
        "last_verified": [
          "February 2017"
        ],
        "first_received": [
          "October 5, 2015"
        ],
        "last_updated": [
          "February 3, 2017"
        ],
        "study_first_submitted": [
          "October 5, 2015"
        ],
        "study_first_posted": [
          "November 4, 2015"
        ],
        "last_update_submitted": [
          "February 3, 2017"
        ],
        "last_update_posted": [
          "February 6, 2017"
        ],
        "locations": [
          {
            "location": [
              "Fakultní nemocnice Královské Vinohrady, Praha, Praha 10, Czech Republic",
              "Nemocnice Na Homolce, Praha, Praha 10, Czech Republic",
              "Všeobecná fakultní nemocnice v Praze, Praha 2, Praha, Czech Republic",
              "Nemocnice Rudolfa a Stefanie Benešov, Benešov, Czech Republic",
              "Nemocnice Jihlava, Jihlava, Czech Republic",
              "Fakultní nemocnice Olomouc, Olomouc, Czech Republic",
              "Nemocnice Slaný, Slaný, Czech Republic",
              "Centre Hospitalier Régional Universitaire de Besançon, Besançon, France",
              "Medical Park Berlin Humboldtmühle, Berlin - Tegel, Berlin, Germany",
              "Klinik am See, Rehabilitationszentrum für innere Medizin, Rüdersdorf, Brandenburg, Germany",
              "Charité - Universitätsmedizin Berlin, Centrum für Schlaganfallforschung (CSB), Berlin, Germany",
              "Brandenburgklinik Berlin-Brandenburg GmbH, Haus Brandenburg/ Kardiologie, Bernau-Waldsiedlung, Germany",
              "Semmelweis Egyetem Városmajori Szív- és Érgyógyászati Klinika, Budapest, Hungary",
              "ASST degli Spedali Civili di Brescia, Brescia, Italy",
              "Ospedale Generale di Zona-Ospedale Valduce, Como, Italy",
              "ASST di Monza-Presidio Ospedaliero di Desio, Desio, Italy",
              "IRCCS Ospedale Policlinico di Milano, Milano, Italy",
              "ASST Rho Dense di Passirana, Passirana-rho, Italy",
              "Ospedale Ss Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy",
              "ASST di Bergamo Ovest-Ospedale Treviglio, Treviglio, Italy",
              "Szpital Wielospecjalistyczny im. Dr. Ludwika Błażka w Inowrocławiu, Inowrocław, Poland",
              "Zespół Opieki Zdrowotnej w Kłodzku, Kłodzko, Poland",
              "Wojewódzki Szpital Specjalistyczny w Legnicy, Legnica, Poland",
              "Specjalistyczny Szpital im. Dra Alfreda Sokołowskiego, Wałbrzych, Poland",
              "Centrum Kardiologiczne \"Pro Corde\" Sp. z o.o., Wrocław, Poland",
              "Wojskowy Szpital Kliniczny z Polikliniką SP ZOZ we Wrocławiu, Wrocław, Poland",
              "Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy, Świdnica, Poland",
              "Hospital Universitario Clínico San Carlos, Madrid, Spain",
              "Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain",
              "Hospital Universitario 12 de Octubre, Madrid, Spain"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02596126"
        ]
      },
      {
        "$": {
          "rank": "28"
        },
        "nct_id": [
          "NCT02613741"
        ],
        "title": [
          "Metabolism of Fibrinogen and Apolipoprotein B-100 in Childhood Obesity and Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Obesity",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Lifestyle-based physical activity",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Protein turnover",
              "Fractional synthesis rate of fibrinogen",
              "Fibrinogen",
              "Fat mass",
              "Fat free mass"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Nemours Children's Clinic"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "14 Years"
        ],
        "max_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "21"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "C.20.8840",
              "0030342B"
            ]
          }
        ],
        "start_date": [
          "January 2001"
        ],
        "primary_completion_date": [
          "January 2004"
        ],
        "completion_date": [
          "January 2017"
        ],
        "last_verified": [
          "November 2015"
        ],
        "first_received": [
          "November 19, 2015"
        ],
        "last_updated": [
          "November 23, 2015"
        ],
        "study_first_submitted": [
          "November 19, 2015"
        ],
        "study_first_posted": [
          "November 24, 2015"
        ],
        "last_update_submitted": [
          "November 23, 2015"
        ],
        "last_update_posted": [
          "November 24, 2015"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02613741"
        ]
      },
      {
        "$": {
          "rank": "29"
        },
        "nct_id": [
          "NCT02931500"
        ],
        "title": [
          "Machine Learning for Identification of Future Disease Development: A Nationwide Cohort Study (MILESTONE)"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Metabolic Disease"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Accuracy in prediction of development of cardiovascular and metabolic disease using machine learning algorithm",
              "Accuracy in prediction of development of cardiovascular and metabolic disease using logistic regression analysis",
              "Accuracy in prediction of development of cardiovascular and metabolic disease using Framingham risk score"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Yonsei University"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "510000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Retrospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "4-2016-0383"
            ]
          }
        ],
        "start_date": [
          "July 2016"
        ],
        "primary_completion_date": [
          "October 2017"
        ],
        "completion_date": [
          "December 2017"
        ],
        "last_verified": [
          "June 2017"
        ],
        "first_received": [
          "July 21, 2016"
        ],
        "last_updated": [
          "June 26, 2017"
        ],
        "study_first_submitted": [
          "July 21, 2016"
        ],
        "study_first_posted": [
          "October 13, 2016"
        ],
        "last_update_submitted": [
          "June 26, 2017"
        ],
        "last_update_posted": [
          "June 28, 2017"
        ],
        "locations": [
          {
            "location": [
              "Yonsei University Severance Hospital, Seoul, Korea, Republic of"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02931500"
        ]
      },
      {
        "$": {
          "rank": "30"
        },
        "nct_id": [
          "NCT02557334"
        ],
        "title": [
          "Effects of Freeze Dried Strawberry Powder Supplementation on Vascular Function and Blood Markers of Cardiovascular Risk"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Low Dose Strawberry Powder",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "High Dose Strawberry Powder",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Placebo Powder",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "LDL-C",
              "Central Blood Pressure",
              "Peripheral Blood Pressure",
              "Augmentation Index",
              "Pulse Wave Velocity",
              "Total Cholesterol",
              "Triglycerides",
              "HDL-C",
              "Oxidized LDL (oxLDL)",
              "Malondialdehyde (MDA)",
              "High Sensitivity C Reactive Protein (hs-CRP)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Penn State University"
            ],
            "collaborator": [
              "California Strawberry Commission"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "35 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "50"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "PKE STRAW II"
            ]
          }
        ],
        "start_date": [
          "October 2015"
        ],
        "primary_completion_date": [
          "April 2018"
        ],
        "completion_date": [
          "April 2018"
        ],
        "last_verified": [
          "January 2017"
        ],
        "first_received": [
          "September 18, 2015"
        ],
        "last_updated": [
          "January 3, 2017"
        ],
        "study_first_submitted": [
          "September 18, 2015"
        ],
        "study_first_posted": [
          "September 23, 2015"
        ],
        "last_update_submitted": [
          "January 3, 2017"
        ],
        "last_update_posted": [
          "January 5, 2017"
        ],
        "locations": [
          {
            "location": [
              "Penn State CRC, University Park, Pennsylvania, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02557334"
        ]
      },
      {
        "$": {
          "rank": "31"
        },
        "nct_id": [
          "NCT02907684"
        ],
        "title": [
          "The Impact of Almond Nut Consumption on Markers of CVD & Metabolic Health"
        ],
        "acronym": [
          "Almonds"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Almonds",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Muffins/Crackers",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Endothelium-dependent vasodilation",
              "Liver fat %",
              "Pancreatic fat",
              "Abdominal fat",
              "Muscle fat",
              "Body composition: body weight",
              "Body composition: body mass index",
              "Body composition: Waist circumference",
              "Body composition: Hip circumference",
              "Blood pressure",
              "24 hour ambulatory blood pressure",
              "24 hour heart rate variability",
              "Fecal short chain fatty acids",
              "Gut microbiota",
              "Fasting insulin",
              "Fasting glucose",
              "Fasting non esterified fatty acids (NEFA)",
              "Plasma Total cholesterol",
              "Plasma LDL cholesterol",
              "Plasma HDL cholesterol",
              "Plasma HDL:LDL ratio",
              "Plasma triglyceride concentration",
              "Homeostasis model assessment estimated insulin resistance (HOMA-IR)",
              "Plasma adiponectin",
              "Plasma resistin",
              "Plasma leptin"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "King's College London"
            ],
            "collaborator": [
              "Almond Board of California"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "30 Years"
        ],
        "max_age": [
          "70 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "100"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Outcomes Assessor)",
              "Primary Purpose: Diagnostic"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "ABC RFP-DHW001"
            ]
          }
        ],
        "start_date": [
          "March 29, 2017"
        ],
        "primary_completion_date": [
          "June 2018"
        ],
        "completion_date": [
          "August 2018"
        ],
        "last_verified": [
          "March 2017"
        ],
        "first_received": [
          "August 30, 2016"
        ],
        "last_updated": [
          "March 30, 2017"
        ],
        "study_first_submitted": [
          "August 30, 2016"
        ],
        "study_first_posted": [
          "September 20, 2016"
        ],
        "last_update_submitted": [
          "March 30, 2017"
        ],
        "last_update_posted": [
          "March 31, 2017"
        ],
        "locations": [
          {
            "location": [
              "King's College London, Diabetes and Nutritional Sciences Division, London, United Kingdom"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02907684"
        ]
      },
      {
        "$": {
          "rank": "32"
        },
        "nct_id": [
          "NCT02508454"
        ],
        "title": [
          "The Miami Heart Study at Baptist Health South Florida"
        ],
        "acronym": [
          "MiHEART"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change from baseline in presence of subclinical cardiovascular disease burden among cohort as measured through yearly followup questionnaire.",
              "Change from baseline in severity of subclinical cardiovascular disease burden among cohort as measured through yearly followup questionnaire.",
              "Associated cost savings of early discovery of disease."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Baptist Health South Florida"
            ],
            "collaborator": [
              "Quest Diagnostics",
              "University of California, Los Angeles"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "4000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "14-042"
            ]
          }
        ],
        "start_date": [
          "August 2014"
        ],
        "primary_completion_date": [
          "May 2023"
        ],
        "completion_date": [
          "May 2023"
        ],
        "last_verified": [
          "January 2017"
        ],
        "first_received": [
          "June 9, 2015"
        ],
        "last_updated": [
          "January 30, 2017"
        ],
        "study_first_submitted": [
          "June 9, 2015"
        ],
        "study_first_posted": [
          "July 27, 2015"
        ],
        "last_update_submitted": [
          "January 30, 2017"
        ],
        "last_update_posted": [
          "January 31, 2017"
        ],
        "locations": [
          {
            "location": [
              "West Kendall Baptist Hospital Medical Arts Building, Suite 103, Miami, Florida, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02508454"
        ]
      },
      {
        "$": {
          "rank": "33"
        },
        "nct_id": [
          "NCT02543996"
        ],
        "title": [
          "Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Undiagnosed Diseases",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "To procure human biospecimens from affected and unaffected cohorts for on-going and future basic and translational research studies to identify underlying disease mechanism(s)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "National Heart, Lung, and Blood Institute (NHLBI)"
            ],
            "collaborator": [
              "National Institutes of Health Clinical Center (CC)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "max_age": [
          "100 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "9999"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "NIH"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Case-Only",
              "Time Perspective: Cross-Sectional"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "150190",
              "15-H-0190"
            ]
          }
        ],
        "start_date": [
          "September 5, 2015"
        ],
        "primary_completion_date": [
          "May 22, 2050"
        ],
        "completion_date": [
          "May 22, 2050"
        ],
        "last_verified": [
          "September 5, 2017"
        ],
        "first_received": [
          "September 5, 2015"
        ],
        "last_updated": [
          "October 18, 2017"
        ],
        "study_first_submitted": [
          "September 5, 2015"
        ],
        "study_first_posted": [
          "September 9, 2015"
        ],
        "last_update_submitted": [
          "October 18, 2017"
        ],
        "last_update_posted": [
          "October 19, 2017"
        ],
        "locations": [
          {
            "location": [
              "National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02543996"
        ]
      },
      {
        "$": {
          "rank": "34"
        },
        "nct_id": [
          "NCT02638129"
        ],
        "title": [
          "Naltrexone/Bupropion Cardiovascular Outcomes Study"
        ],
        "recruitment": [
          {
            "_": "Terminated",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "Has Results"
        ],
        "conditions": [
          {
            "condition": [
              "Obesity",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Naltrexone HCl/Bupropion HCl ER",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Time From Treatment Period Randomization to the First Confirmed Occurrence of Major Adverse Cardiovascular Events (MACE)",
              "Time From Treatment Period Randomization to the First Confirmed Occurrence of Extended Major Adverse Cardiovascular Events (MACE)",
              "Time From Treatment Period Randomization to the Occurrence of All-Cause Death",
              "Time From Treatment Period Randomization to the Occurrence of Cardiovascular Death"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Orexigen Therapeutics, Inc"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 4"
            ]
          }
        ],
        "enrollment": [
          "67"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "NaltrexBuprop-4001",
              "U1111-1169-1350"
            ]
          }
        ],
        "start_date": [
          "January 2016"
        ],
        "primary_completion_date": [
          "June 2016"
        ],
        "completion_date": [
          "June 2016"
        ],
        "last_verified": [
          "October 2016"
        ],
        "first_received": [
          "December 18, 2015"
        ],
        "firstreceived_results_date": [
          "October 5, 2016"
        ],
        "last_updated": [
          "February 21, 2017"
        ],
        "study_first_submitted": [
          "December 18, 2015"
        ],
        "study_first_posted": [
          "December 22, 2015"
        ],
        "results_first_submitted": [
          "October 5, 2016"
        ],
        "results_first_posted": [
          "February 27, 2017"
        ],
        "last_update_submitted": [
          "February 21, 2017"
        ],
        "last_update_posted": [
          "February 27, 2017"
        ],
        "locations": [
          {
            "location": [
              "Alexander City, Alabama, United States",
              "Auburn, Alabama, United States",
              "Birmingham, Alabama, United States",
              "Huntsville, Alabama, United States",
              "Campe Verde, Arizona, United States",
              "Chandler, Arizona, United States",
              "Cottonwood, Arizona, United States",
              "Fountain Hills, Arizona, United States",
              "Mesa, Arizona, United States",
              "Phoenix, Arizona, United States",
              "Tucson, Arizona, United States",
              "Fayetteville, Arkansas, United States",
              "Jonesboro, Arkansas, United States",
              "Little Rock, Arkansas, United States",
              "Arvin, California, United States",
              "Bakersfield, California, United States",
              "Chino, California, United States",
              "Downey, California, United States",
              "El Cajon, California, United States",
              "Los Alamitos, California, United States",
              "Los Angeles, California, United States",
              "Pamona, California, United States",
              "Sacramento, California, United States",
              "Santa Ana, California, United States",
              "Santa Monica, California, United States",
              "Denver, Colorado, United States",
              "New London, Connecticut, United States",
              "Stamford, Connecticut, United States",
              "Trumbull, Connecticut, United States",
              "Waterbury, Connecticut, United States",
              "Wilmington, Delaware, United States",
              "Boca Raton, Florida, United States",
              "Bradenton, Florida, United States",
              "Brandon, Florida, United States",
              "Brooksville, Florida, United States",
              "Coral Springs, Florida, United States",
              "Cutler Bay, Florida, United States",
              "Daytona Beach, Florida, United States",
              "Hialeah, Florida, United States",
              "Inverness, Florida, United States",
              "Jacksonville Beach, Florida, United States",
              "Lake Worth, Florida, United States",
              "Largo, Florida, United States",
              "Miami Lakes, Florida, United States",
              "Orlando, Florida, United States",
              "Palm Harbor, Florida, United States",
              "Pembroke Pines, Florida, United States",
              "Ponte Vedra Beach, Florida, United States",
              "Sarasota, Florida, United States",
              "Stuart, Florida, United States",
              "Atlanta, Georgia, United States",
              "Duluth, Georgia, United States",
              "Savannah, Georgia, United States",
              "Honolulu, Hawaii, United States",
              "Pocatello, Idaho, United States",
              "Blue Island, Illinois, United States",
              "Chicago, Illinois, United States",
              "Evanston, Illinois, United States",
              "Gurnee, Illinois, United States",
              "Rock Island, Illinois, United States",
              "Evansville, Indiana, United States",
              "Topeka, Kansas, United States",
              "Louisville, Kentucky, United States",
              "Owensboro, Kentucky, United States",
              "Baton Rouge, Louisiana, United States",
              "Bossier City, Louisiana, United States",
              "Lake Charles, Louisiana, United States",
              "Shreveport, Louisiana, United States",
              "Baltimore, Maryland, United States",
              "Catonsville, Maryland, United States",
              "Bay City, Michigan, United States",
              "Saginaw, Michigan, United States",
              "Port Gibson, Mississippi, United States",
              "Hazelwood, Missouri, United States",
              "Great Falls, Montana, United States",
              "Las Vegas, Nevada, United States",
              "Linden, New Jersey, United States",
              "Moorestown, New Jersey, United States",
              "Albuquerque, New Mexico, United States",
              "Endwell, New York, United States",
              "Great Neck, New York, United States",
              "Mineola, New York, United States",
              "New York, New York, United States",
              "Saratoga Springs, New York, United States",
              "Staten Island, New York, United States",
              "Asheville, North Carolina, United States",
              "Cary, North Carolina, United States",
              "Charlotte, North Carolina, United States",
              "Durham, North Carolina, United States",
              "Greenville, North Carolina, United States",
              "Hickory, North Carolina, United States",
              "Morehead City, North Carolina, United States",
              "Raleigh, North Carolina, United States",
              "Rocky Mount, North Carolina, United States",
              "Salisbury, North Carolina, United States",
              "Winston Salem, North Carolina, United States",
              "Canton, Ohio, United States",
              "Cincinnati, Ohio, United States",
              "Cleveland, Ohio, United States",
              "Columbus, Ohio, United States",
              "Perrysburg, Ohio, United States",
              "Sandusky, Ohio, United States",
              "Willoughby, Ohio, United States",
              "Altoona, Pennsylvania, United States",
              "Camp Hill, Pennsylvania, United States",
              "Doylestown, Pennsylvania, United States",
              "Lansdale, Pennsylvania, United States",
              "Pittsburgh, Pennsylvania, United States",
              "Smithfield, Pennsylvania, United States",
              "Yardley, Pennsylvania, United States",
              "Charleston, South Carolina, United States",
              "Moncks Corner, South Carolina, United States",
              "Mount Pleasant, South Carolina, United States",
              "Simpsonville, South Carolina, United States",
              "Bristol, Tennessee, United States",
              "Jackson, Tennessee, United States",
              "Knoxville, Tennessee, United States",
              "Memphis, Tennessee, United States",
              "Arlington, Texas, United States",
              "Dallas, Texas, United States",
              "Houston, Texas, United States",
              "Katy, Texas, United States",
              "Kingwood, Texas, United States",
              "Palestine, Texas, United States",
              "Plano, Texas, United States",
              "San Antonio, Texas, United States",
              "Bountiful, Utah, United States",
              "Murray, Utah, United States",
              "Ogden, Utah, United States",
              "Orem, Utah, United States",
              "South Ogden, Utah, United States",
              "West Jordan, Utah, United States",
              "West, Utah, United States",
              "Richmond, Virginia, United States",
              "Roanoke, Virginia, United States",
              "Virginia Beach, Virginia, United States",
              "Port Orchard, Washington, United States",
              "Charleston, West Virginia, United States",
              "Kenosha, Wisconsin, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02638129"
        ]
      },
      {
        "$": {
          "rank": "35"
        },
        "nct_id": [
          "NCT02515747"
        ],
        "title": [
          "Prospective Russian Evaluation of Lp(a) Role in cardiovascUlar DiseasE"
        ],
        "acronym": [
          "PRELUDE"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Coronary Disease",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "percutaneous coronary intervention",
                "$": {
                  "type": "Procedure"
                }
              },
              {
                "_": "coronary artery bypass grafting",
                "$": {
                  "type": "Procedure"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "non-fatal myocardial infarction and cardiovascular death",
              "non-fatal myocardial infarction and cardiovascular death and myocardial revascularisation and hospitalization for recurrent or unstable angina"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Russian Cardiology Research and Production Center"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "1400"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Non-Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "01200406198"
            ]
          }
        ],
        "start_date": [
          "January 1993"
        ],
        "primary_completion_date": [
          "September 2006"
        ],
        "completion_date": [
          "January 2014"
        ],
        "last_verified": [
          "August 2015"
        ],
        "first_received": [
          "May 8, 2015"
        ],
        "last_updated": [
          "August 1, 2015"
        ],
        "study_first_submitted": [
          "May 8, 2015"
        ],
        "study_first_posted": [
          "August 5, 2015"
        ],
        "last_update_submitted": [
          "August 1, 2015"
        ],
        "last_update_posted": [
          "August 5, 2015"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02515747"
        ]
      },
      {
        "$": {
          "rank": "36"
        },
        "nct_id": [
          "NCT02976246"
        ],
        "title": [
          "Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients"
        ],
        "acronym": [
          "RenaKvit"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Vitamin K Supplementation",
              "Endstage Renal Disease",
              "Cardiovascular Disease",
              "Bone Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Vitamin K2 (MK7)",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "For RenaKvit-vessel: Changes in arterial stiffness assessed by pulse wave examination reflecting vascular calcification (unit: m/s).",
              "For RenaKvit-bone: Changes in bone mineral density (BMD) in the distal radial bone (unit T-score).",
              "For RenaKvit-vessel: Changes in coronary vascular and -valve calcification assessed by CT-scans of the heart (unit: Agatston-Score).",
              "For RenaKvit-vessel: Changes in vascular calcification measured by changes in blood pressure measurements (unit: mmHg).",
              "For RenaKvit-bone: Changes in body composition, BMD in the lumbar column, hip and whole body (unit: T-score).",
              "For RenaKvit-bone: Changes in abdominal aortic calcification measured by lateral X-ray of lumbar column (unit: abdominal aortic calcification score)."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Zealand University Hospital"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 2",
              "Phase 3"
            ]
          }
        ],
        "enrollment": [
          "140"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "RenaKvit"
            ]
          }
        ],
        "start_date": [
          "November 2016"
        ],
        "primary_completion_date": [
          "June 2019"
        ],
        "completion_date": [
          "August 2020"
        ],
        "last_verified": [
          "November 2016"
        ],
        "first_received": [
          "November 3, 2016"
        ],
        "last_updated": [
          "November 28, 2016"
        ],
        "study_first_submitted": [
          "November 3, 2016"
        ],
        "study_first_posted": [
          "November 29, 2016"
        ],
        "last_update_submitted": [
          "November 28, 2016"
        ],
        "last_update_posted": [
          "November 29, 2016"
        ],
        "locations": [
          {
            "location": [
              "Holbaek Hospital, Holbaek, Denmark",
              "Zealand University Hospital, Roskilde, Denmark"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02976246"
        ]
      },
      {
        "$": {
          "rank": "37"
        },
        "nct_id": [
          "NCT02716259"
        ],
        "title": [
          "Periodontal and Cardiovascular Diseases Project"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Periodontitis",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Scaling and root planing",
                "$": {
                  "type": "Procedure"
                }
              },
              {
                "_": "Supragingival prophylaxis",
                "$": {
                  "type": "Procedure"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Flow mediated dilation of the brachial artery",
              "Carotid artery atherosclerosis",
              "Periodontal pocket probing depth",
              "Gingival recession",
              "Plaque index",
              "Bleeding on probing index",
              "Suppuration on probing index",
              "Dental mobility",
              "Furcation lesions",
              "Number of present teeth",
              "Radiographic bone loss",
              "Bacteria in gingival crevicular fluid",
              "Bacteria in blood samples",
              "Inflammatory biomarkers in serum samples"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Universidad Complutense de Madrid"
            ],
            "collaborator": [
              "Instituto de Salud Carlos III"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "120"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Triple (Participant, Investigator, Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "14/120-E_BS",
              "PI11/00542"
            ]
          }
        ],
        "start_date": [
          "March 2016"
        ],
        "primary_completion_date": [
          "March 2018"
        ],
        "completion_date": [
          "March 2018"
        ],
        "last_verified": [
          "April 2016"
        ],
        "first_received": [
          "March 17, 2016"
        ],
        "last_updated": [
          "April 2, 2016"
        ],
        "study_first_submitted": [
          "March 17, 2016"
        ],
        "study_first_posted": [
          "March 23, 2016"
        ],
        "last_update_submitted": [
          "April 2, 2016"
        ],
        "last_update_posted": [
          "April 5, 2016"
        ],
        "locations": [
          {
            "location": [
              "Severo Ochoa Hospital, Leganes, Madrid, Spain",
              "Faculty of dentistry, Complutense University Madrid, Madrid, Spain"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02716259"
        ]
      },
      {
        "$": {
          "rank": "38"
        },
        "nct_id": [
          "NCT02428634"
        ],
        "title": [
          "The Program SI! for Cardiovascular Health Promotion at Elementary School"
        ],
        "acronym": [
          "PSIE"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "PSIE13",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "PSIE46",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Difference between control and intervention groups in the mean change in questionnaire's scoring from baseline to 3-year and 6-year intervention for children.",
              "Cardiovascular health markers (blood pressure, height, weight, waist circumference and triceps and subscapular skinfold thickness) of children from baseline to 3-year and 6-year intervention.",
              "Difference between control and intervention groups in the mean change in questionnaire's scoring from baseline to post-intervention for families.",
              "Difference between control and intervention groups in the mean change in questionnaire's scoring from baseline to post-intervention for teachers",
              "Difference between control and intervention groups in the mean change in questionnaire's scoring from baseline to post-intervention for school environment"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Foundation for Science, Health and Education, Spain"
            ],
            "collaborator": [
              "Fondation Daniel & Nina Carasso"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "5 Years"
        ],
        "max_age": [
          "6 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "2238"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "SHE-002-SI"
            ]
          }
        ],
        "start_date": [
          "September 2014"
        ],
        "primary_completion_date": [
          "June 2020"
        ],
        "completion_date": [
          "June 2020"
        ],
        "last_verified": [
          "August 2016"
        ],
        "first_received": [
          "April 8, 2015"
        ],
        "last_updated": [
          "August 9, 2016"
        ],
        "study_first_submitted": [
          "April 8, 2015"
        ],
        "study_first_posted": [
          "April 29, 2015"
        ],
        "last_update_submitted": [
          "August 9, 2016"
        ],
        "last_update_posted": [
          "August 10, 2016"
        ],
        "locations": [
          {
            "location": [
              "Foundation for Science, Health and Education, Madrid, Spain"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02428634"
        ]
      },
      {
        "$": {
          "rank": "39"
        },
        "nct_id": [
          "NCT02899442"
        ],
        "title": [
          "Cardiovascular Risk Prevention Among Night Workers"
        ],
        "acronym": [
          "Heart-Of-Night"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "collective prevention in workplace",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change of Metabolic Syndrome Factors",
              "Change of preventive interventions"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University Hospital, Toulouse"
            ],
            "collaborator": [
              "assistance of the French National Health Insurance Fund for Employees (CNAMTS)",
              "French Directorate General of Health (DGS)",
              "ARC Foundation for Cancer Research",
              "National Cancer Institute, France",
              "French National Institute for Prevention and Education in Health (INPES)",
              "Institut National de la Santé Et de la Recherche Médicale, France",
              "French Inter-Departemental Agency for the Fight against Drugs and Addictive Behaviors (Mildeca)",
              "French Social Security Scheme for Liberal Professionals (RSI)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "3056"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "14 7341 03"
            ]
          }
        ],
        "start_date": [
          "September 2015"
        ],
        "primary_completion_date": [
          "September 2018"
        ],
        "completion_date": [
          "September 2019"
        ],
        "last_verified": [
          "September 2016"
        ],
        "first_received": [
          "September 2, 2016"
        ],
        "last_updated": [
          "September 8, 2016"
        ],
        "study_first_submitted": [
          "September 2, 2016"
        ],
        "study_first_posted": [
          "September 14, 2016"
        ],
        "last_update_submitted": [
          "September 8, 2016"
        ],
        "last_update_posted": [
          "September 14, 2016"
        ],
        "locations": [
          {
            "location": [
              "Toulouse University Hospital (CHU de Toulouse), Toulouse, France"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02899442"
        ]
      },
      {
        "$": {
          "rank": "40"
        },
        "nct_id": [
          "NCT02931305"
        ],
        "title": [
          "Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Osteoporosis",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Epimedium Prenylflavonoids Extract",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Incidence and severity of adverse events/serious adverse events",
              "lcariin",
              "Ex vivo osteoblast and osteoclast activities",
              "Estrogenic biomarkers",
              "interleukin-6 (IL-6)",
              "high-sensitivity C-reactive protein (hs-CRP)",
              "F2-isoprostanes",
              "multiple platelet aggregation",
              "Icaritin (ICT)",
              "Demethylicaritin (DICT)",
              "icariside 1",
              "icariside II"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "National University Hospital, Singapore"
            ]
          }
        ],
        "gender": [
          "Male"
        ],
        "min_age": [
          "21 Years"
        ],
        "max_age": [
          "45 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 1"
            ]
          }
        ],
        "enrollment": [
          "30"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Double (Participant, Investigator)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "EP2016"
            ]
          }
        ],
        "start_date": [
          "October 2016"
        ],
        "primary_completion_date": [
          "January 2017"
        ],
        "completion_date": [
          "October 2017"
        ],
        "last_verified": [
          "October 2016"
        ],
        "first_received": [
          "October 6, 2016"
        ],
        "last_updated": [
          "October 12, 2016"
        ],
        "study_first_submitted": [
          "October 6, 2016"
        ],
        "study_first_posted": [
          "October 13, 2016"
        ],
        "last_update_submitted": [
          "October 12, 2016"
        ],
        "last_update_posted": [
          "October 14, 2016"
        ],
        "locations": [
          {
            "location": [
              "Investigational Medicine Unit, National University Health System, Singapore, Singapore"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02931305"
        ]
      },
      {
        "$": {
          "rank": "41"
        },
        "nct_id": [
          "NCT02773823"
        ],
        "title": [
          "A Behavior Intervention Study on Cardiovascular Health Among Chinese Obese Schoolchildren"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Intervention group",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Body weight of study children",
              "Body mass index of study children",
              "Waist circumference of study children",
              "Blood pressure",
              "Blood lipids",
              "Blood glucose",
              "cardiorespiratory fitness of study children",
              "Well-being of study children",
              "Depression of study children"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Wuhan University"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "8 Years"
        ],
        "max_age": [
          "12 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "200"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "81372973"
            ]
          }
        ],
        "start_date": [
          "November 2015"
        ],
        "primary_completion_date": [
          "June 2016"
        ],
        "completion_date": [
          "June 2017"
        ],
        "last_verified": [
          "May 2016"
        ],
        "first_received": [
          "May 7, 2016"
        ],
        "last_updated": [
          "May 13, 2016"
        ],
        "study_first_submitted": [
          "May 7, 2016"
        ],
        "study_first_posted": [
          "May 16, 2016"
        ],
        "last_update_submitted": [
          "May 13, 2016"
        ],
        "last_update_posted": [
          "May 17, 2016"
        ],
        "locations": [
          {
            "location": [
              "Wuhan university, Wuhan, Hubei, China"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02773823"
        ]
      },
      {
        "$": {
          "rank": "42"
        },
        "nct_id": [
          "NCT02475057"
        ],
        "title": [
          "Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Prostatic Neoplasms",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Degarelix (LHRH antagonist)",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "LHRH agonist",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "EndoPAT2000",
                "$": {
                  "type": "Device"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in Reactive Hyperemia Index from baseline to twelve months",
              "Change in High sensitivity troponin (hsTn) value",
              "Change in C-reactive protein value",
              "Change in D-dimer value",
              "Change in N-terminal pro-brain natriuretic peptide (NT-proBNP) value"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Rabin Medical Center"
            ],
            "collaborator": [
              "Ferring Pharmaceuticals"
            ]
          }
        ],
        "gender": [
          "Male"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "90 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 4"
            ]
          }
        ],
        "enrollment": [
          "80"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Other"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "0102-15-RMC"
            ]
          }
        ],
        "start_date": [
          "August 2015"
        ],
        "primary_completion_date": [
          "June 2018"
        ],
        "completion_date": [
          "August 2018"
        ],
        "last_verified": [
          "July 2017"
        ],
        "first_received": [
          "June 8, 2015"
        ],
        "last_updated": [
          "July 13, 2017"
        ],
        "study_first_submitted": [
          "June 8, 2015"
        ],
        "study_first_posted": [
          "June 18, 2015"
        ],
        "last_update_submitted": [
          "July 13, 2017"
        ],
        "last_update_posted": [
          "July 18, 2017"
        ],
        "locations": [
          {
            "location": [
              "Rambam Health Care Campus, Haifa, Israel",
              "Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02475057"
        ]
      },
      {
        "$": {
          "rank": "43"
        },
        "nct_id": [
          "NCT02715661"
        ],
        "title": [
          "Cerebrovascular Outcomes in Ischemic Heart Disease"
        ],
        "acronym": [
          "IHD"
        ],
        "recruitment": [
          {
            "_": "Not yet recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "exercise",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "cerebrovascular properties",
              "1) vascular cognitive impairment",
              "2) Brain grey matter and white matter mass, white matter hyperintensities",
              "3) blood borne markers of inflammation",
              "4) vascular endothelial damage"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Western University, Canada"
            ],
            "collaborator": [
              "Lawson Health Research Institute"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "80 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "270"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Basic Science"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "107620"
            ]
          }
        ],
        "start_date": [
          "March 2016"
        ],
        "primary_completion_date": [
          "June 2019"
        ],
        "completion_date": [
          "June 2019"
        ],
        "last_verified": [
          "March 2016"
        ],
        "first_received": [
          "March 7, 2016"
        ],
        "last_updated": [
          "March 16, 2016"
        ],
        "study_first_submitted": [
          "March 7, 2016"
        ],
        "study_first_posted": [
          "March 22, 2016"
        ],
        "last_update_submitted": [
          "March 16, 2016"
        ],
        "last_update_posted": [
          "March 22, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02715661"
        ]
      },
      {
        "$": {
          "rank": "44"
        },
        "nct_id": [
          "NCT02637778"
        ],
        "title": [
          "Modulation of Cardiovascular Risk Factors by the Diet"
        ],
        "acronym": [
          "MoKaRi-Diet"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Cardioprotective diet",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Cardioprotective diet + 3 g EPA + DHA/d",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "blood lipids",
              "fatty acid distribution (blood)",
              "insulin (blood)",
              "HbA1c (blood)",
              "oral glucose tolerance test (blood)",
              "alpha prothrombin time (blood)",
              "fibrinogen (blood)",
              "Nutritional status I (blood)",
              "Nutritional status II (blood)",
              "Nutritional status III (blood)",
              "homocysteine (blood)",
              "high sensitive c-reactive protein (blood)",
              "lipoprotein(a) (blood)",
              "height",
              "weight"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Jena"
            ],
            "collaborator": [
              "German Federal Ministry of Education and Research"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "20 Years"
        ],
        "max_age": [
          "80 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "60"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "H2_16"
            ]
          }
        ],
        "start_date": [
          "February 2016"
        ],
        "primary_completion_date": [
          "June 2016"
        ],
        "completion_date": [
          "November 2016"
        ],
        "last_verified": [
          "December 2015"
        ],
        "first_received": [
          "December 15, 2015"
        ],
        "last_updated": [
          "February 19, 2017"
        ],
        "study_first_submitted": [
          "December 15, 2015"
        ],
        "study_first_posted": [
          "December 22, 2015"
        ],
        "last_update_submitted": [
          "February 19, 2017"
        ],
        "last_update_posted": [
          "February 23, 2017"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02637778"
        ]
      },
      {
        "$": {
          "rank": "45"
        },
        "nct_id": [
          "NCT02496728"
        ],
        "title": [
          "NUYou:mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health"
        ],
        "acronym": [
          "NUYou"
        ],
        "recruitment": [
          {
            "_": "Enrolling by invitation",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Mobile Health Application",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Environmental Cues",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Social Support",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Educational Materials",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "American Heart Association MyLifeCheck (Simple 7) score as a measure of cardiovascular health"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Northwestern University"
            ],
            "collaborator": [
              "American Heart Association"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "17 Years"
        ],
        "max_age": [
          "26 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "700"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "14SFRN20480260"
            ]
          }
        ],
        "start_date": [
          "May 2015"
        ],
        "primary_completion_date": [
          "November 2018"
        ],
        "completion_date": [
          "July 2019"
        ],
        "last_verified": [
          "June 2017"
        ],
        "first_received": [
          "May 29, 2015"
        ],
        "last_updated": [
          "June 8, 2017"
        ],
        "study_first_submitted": [
          "May 29, 2015"
        ],
        "study_first_posted": [
          "July 14, 2015"
        ],
        "last_update_submitted": [
          "June 8, 2017"
        ],
        "last_update_posted": [
          "June 12, 2017"
        ],
        "locations": [
          {
            "location": [
              "Northwestern University, Chicago, Illinois, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02496728"
        ]
      },
      {
        "$": {
          "rank": "46"
        },
        "nct_id": [
          "NCT02770872"
        ],
        "title": [
          "The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Observation of SAA on apoB containing lipoproteins",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Post-prandial SAA content on apoB containing lipoproteins after consumption of a high fat shake",
              "Degree of insulin resistance"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Lisa Tannock"
            ],
            "collaborator": [
              "VA Office of Research and Development",
              "University of Kentucky"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "75"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "U.S. Fed"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Case-Control",
              "Time Perspective: Cross-Sectional"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "TAN-14-002-HAF"
            ]
          }
        ],
        "start_date": [
          "February 2014"
        ],
        "primary_completion_date": [
          "February 2018"
        ],
        "completion_date": [
          "February 2018"
        ],
        "last_verified": [
          "April 2017"
        ],
        "first_received": [
          "May 11, 2015"
        ],
        "last_updated": [
          "April 10, 2017"
        ],
        "study_first_submitted": [
          "May 11, 2015"
        ],
        "study_first_posted": [
          "May 12, 2016"
        ],
        "last_update_submitted": [
          "April 10, 2017"
        ],
        "last_update_posted": [
          "April 12, 2017"
        ],
        "locations": [
          {
            "location": [
              "VA Medical Center, Lexington, Kentucky, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02770872"
        ]
      },
      {
        "$": {
          "rank": "47"
        },
        "nct_id": [
          "NCT02845063"
        ],
        "title": [
          "Effect of ACE Genotype on Cardiovascular Rehabilitation"
        ],
        "acronym": [
          "ACE-REHAB"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "concentric cardiovascular training",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "eccentric cardiovascular training",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "ACE genotyping",
                "$": {
                  "type": "Genetic"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "ACE I/D genotype",
              "Molecular muscle characteristics - mRNA",
              "Molecular muscle characteristics- protein",
              "Molecular muscle characteristics- phosphorylation",
              "Molecular muscle characteristics- ACE",
              "Cellular muscle characteristics - fiber type %",
              "Cellular muscle characteristics - fiber area %",
              "Cellular muscle characteristics - fiber type CSA",
              "Cellular muscle characteristics - Capillary density",
              "Cellular muscle characteristics - Capillary-to-fiber ratio",
              "Functional muscle characteristics - Maximal Power",
              "Functional muscle characteristics - Critical Power",
              "Functional muscle characteristics - Real Power",
              "Functional muscle characteristics - Reactive Power",
              "Functional muscle characteristics - Negative Power",
              "Functional muscle characteristics - Maximal force",
              "Functional muscle characteristics - Maximal velocity",
              "Functional muscle characteristics - Rate of force development",
              "Muscle metabolism - muscle oxygenation ramp",
              "Muscle metabolism - muscle oxygenation robot exercise",
              "Muscle metabolism - hemoglobin ramp",
              "Muscle metabolism - hemoglobin robot exercise",
              "Muscle metabolism - lipid compounds",
              "Muscle metabolism - metabolites",
              "Muscle metabolism - serum glucose",
              "Muscle metabolism - serum lactate",
              "Cardiovascular function - Heart rate rest",
              "Cardiovascular function - Heart rate ramp",
              "Cardiovascular function - cardiac output",
              "Cardiovascular function - ejection fraction",
              "Cardiovascular function - Maximal oxygen uptake",
              "Cardiovascular function - ventilation",
              "Cardiovascular function - ventilation frequency",
              "Cardiovascular function - respiration quotient",
              "Cardiovascular function - endurance"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Balgrist University Hospital"
            ],
            "collaborator": [
              "University of Zurich"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "20 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 2"
            ]
          }
        ],
        "enrollment": [
          "60"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Non-Randomized",
              "Intervention Model: Factorial Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "W 549 ACE-REHAB",
              "KEK-ZH-Nr. 2014-0319"
            ]
          }
        ],
        "start_date": [
          "May 2016"
        ],
        "primary_completion_date": [
          "January 2019"
        ],
        "completion_date": [
          "January 2020"
        ],
        "last_verified": [
          "May 2016"
        ],
        "first_received": [
          "November 27, 2015"
        ],
        "last_updated": [
          "August 6, 2016"
        ],
        "study_first_submitted": [
          "November 27, 2015"
        ],
        "study_first_posted": [
          "July 27, 2016"
        ],
        "last_update_submitted": [
          "August 6, 2016"
        ],
        "last_update_posted": [
          "August 9, 2016"
        ],
        "locations": [
          {
            "location": [
              "Balgrist University Hospital, Zurich, Switzerland",
              "University Hospital Zurich, Zurich, Switzerland"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02845063"
        ]
      },
      {
        "$": {
          "rank": "48"
        },
        "nct_id": [
          "NCT02569385"
        ],
        "title": [
          "Examination of Cardiovascular Function/ Cardio Respiratory Interaction on Spontaneous Breathing Trials in Patients in the Prolonged Weaning"
        ],
        "acronym": [
          "Weaning TTE"
        ],
        "recruitment": [
          {
            "_": "Unknown status",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Spontaneous breathing trial",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Baseline measurement (Modus \"CPAP-PS\") in patient with prolonged weaning",
              "Intervention measurement in patient with prolonged weaning"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "RWTH Aachen University"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "20"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Case-Only",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "CTC-A 15-034"
            ]
          }
        ],
        "start_date": [
          "August 2015"
        ],
        "primary_completion_date": [
          "August 2016"
        ],
        "completion_date": [
          "August 2016"
        ],
        "last_verified": [
          "August 2015"
        ],
        "first_received": [
          "September 23, 2015"
        ],
        "last_updated": [
          "October 2, 2015"
        ],
        "study_first_submitted": [
          "September 23, 2015"
        ],
        "study_first_posted": [
          "October 6, 2015"
        ],
        "last_update_submitted": [
          "October 2, 2015"
        ],
        "last_update_posted": [
          "October 6, 2015"
        ],
        "locations": [
          {
            "location": [
              "University Hospital RWTH Aachen, Department of Medical Clinic I, Aachen, 52074, Germany"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02569385"
        ]
      },
      {
        "$": {
          "rank": "49"
        },
        "nct_id": [
          "NCT02913339"
        ],
        "title": [
          "mHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina."
        ],
        "acronym": [
          "mHealth"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "mHealth Risk Assessment",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Impact of mHealth app on rate of uninsured persons who are at risk and attend a first visit with a health professional at a local government primary care clinic.",
              "Impact of mHealth app on rate of uninsured persons who are at risk and attend a follow-up visit, after baseline, with a health professional at a local government primary care clinic."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Brigham and Women's Hospital"
            ],
            "collaborator": [
              "Institute for Clinical Effectiveness and Health Policy"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "740"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Screening"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "2015P002360"
            ]
          }
        ],
        "start_date": [
          "January 2016"
        ],
        "primary_completion_date": [
          "July 2017"
        ],
        "completion_date": [
          "December 2017"
        ],
        "last_verified": [
          "September 2016"
        ],
        "first_received": [
          "September 21, 2016"
        ],
        "last_updated": [
          "September 21, 2016"
        ],
        "study_first_submitted": [
          "September 21, 2016"
        ],
        "study_first_posted": [
          "September 23, 2016"
        ],
        "last_update_submitted": [
          "September 21, 2016"
        ],
        "last_update_posted": [
          "September 23, 2016"
        ],
        "locations": [
          {
            "location": [
              "IECS- Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Buenos Aires Province, Argentina"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02913339"
        ]
      },
      {
        "$": {
          "rank": "50"
        },
        "nct_id": [
          "NCT02732223"
        ],
        "title": [
          "Combined Bioactive Therapy Effects Over Cardiovascular Markers in Statin Treated Patients"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Functional treatment",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Control treatment",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "LDL",
              "C-reactive protein",
              "Malondialdehyde",
              "Omega 3 fatty acids profile",
              "Cholesterol synthesis and absorption markers",
              "Antioxidant enzymes activity"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Instituto Dante Pazzanese de Cardiologia"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "70 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "53"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Single (Participant)"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "NºCAAE 27349114.5.3001.0067"
            ]
          }
        ],
        "start_date": [
          "May 2014"
        ],
        "primary_completion_date": [
          "December 2014"
        ],
        "completion_date": [
          "December 2015"
        ],
        "last_verified": [
          "April 2016"
        ],
        "first_received": [
          "April 4, 2016"
        ],
        "last_updated": [
          "April 7, 2016"
        ],
        "study_first_submitted": [
          "April 4, 2016"
        ],
        "study_first_posted": [
          "April 8, 2016"
        ],
        "last_update_submitted": [
          "April 7, 2016"
        ],
        "last_update_posted": [
          "April 8, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02732223"
        ]
      },
      {
        "$": {
          "rank": "51"
        },
        "nct_id": [
          "NCT02851732"
        ],
        "title": [
          "Brazilian inteRvention to Increase eviDence usaGe in practicE - Cardiovascular Prevention"
        ],
        "acronym": [
          "BRIDGE-CV"
        ],
        "recruitment": [
          {
            "_": "Not yet recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Educational multifaceted intervention",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Adherence",
              "Adherence to lipid lowering agents, aspirin and ACE Inhibitors"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Hospital do Coracao"
            ],
            "collaborator": [
              "Amgen"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "1687"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "BRIDGE0003"
            ]
          }
        ],
        "start_date": [
          "September 2016"
        ],
        "primary_completion_date": [
          "December 2017"
        ],
        "completion_date": [
          "April 2018"
        ],
        "last_verified": [
          "July 2016"
        ],
        "first_received": [
          "July 28, 2016"
        ],
        "last_updated": [
          "July 28, 2016"
        ],
        "study_first_submitted": [
          "July 28, 2016"
        ],
        "study_first_posted": [
          "August 2, 2016"
        ],
        "last_update_submitted": [
          "July 28, 2016"
        ],
        "last_update_posted": [
          "August 2, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02851732"
        ]
      },
      {
        "$": {
          "rank": "52"
        },
        "nct_id": [
          "NCT02575976"
        ],
        "title": [
          "Effects of Cardiac Rehabilitation on Functional Capacity and Cardiovascular Risk Factors"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Coronary Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "comprehensive CR",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "exercise-based CR",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "wait list control",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Functional capacity",
              "Risk Factors"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Federal University of Minas Gerais"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "115"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "RCT-898235"
            ]
          }
        ],
        "start_date": [
          "March 2015"
        ],
        "primary_completion_date": [
          "October 2017"
        ],
        "completion_date": [
          "October 2017"
        ],
        "last_verified": [
          "May 2017"
        ],
        "first_received": [
          "October 12, 2015"
        ],
        "last_updated": [
          "May 3, 2017"
        ],
        "study_first_submitted": [
          "October 12, 2015"
        ],
        "study_first_posted": [
          "October 15, 2015"
        ],
        "last_update_submitted": [
          "May 3, 2017"
        ],
        "last_update_posted": [
          "May 4, 2017"
        ],
        "locations": [
          {
            "location": [
              "Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02575976"
        ]
      },
      {
        "$": {
          "rank": "53"
        },
        "nct_id": [
          "NCT02344290"
        ],
        "title": [
          "Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults"
        ],
        "acronym": [
          "REPRIEVE"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "HIV Infections",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Pitavastatin",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Time to the first event of a composite of major cardiovascular events",
              "Time to the first of each individual component of the primary endpoint",
              "Time to death (all-cause mortality)",
              "Time to death (all-cause mortality) and/or major adverse cardiovascular events (MACE)",
              "Time to any (composite) or each (individual) of the following clinical diagnoses (including recurrent diagnoses as appropriate)",
              "Calculated fasting low-density lipoprotein (LDL) and non-high-density lipoprotein (HDL) cholesterol level",
              "Time to any of the following adverse events (including recurrent events as appropriate)",
              "For substudy: evidence of non-calcified coronary atherosclerotic plaque (NCP)",
              "For substudy: volume of NCP at study entry and change in NCP over 2 years",
              "For substudy: progression of NCP",
              "For substudy: number of high risk plaque features",
              "For substudy: changes in inflammatory markers",
              "For substudy: changes in markers of glucose homeostasis"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "National Institute of Allergy and Infectious Diseases (NIAID)"
            ],
            "collaborator": [
              "National Heart, Lung, and Blood Institute (NHLBI)",
              "Kowa Pharmaceuticals America, Inc."
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "75 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 4"
            ]
          }
        ],
        "enrollment": [
          "6500"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "NIH",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "A5332",
              "11960",
              "1U01HL123339-01",
              "1U01HL123336-01"
            ]
          }
        ],
        "start_date": [
          "March 2015"
        ],
        "primary_completion_date": [
          "April 2020"
        ],
        "completion_date": [
          "April 2020"
        ],
        "last_verified": [
          "October 2017"
        ],
        "first_received": [
          "January 16, 2015"
        ],
        "last_updated": [
          "October 17, 2017"
        ],
        "study_first_submitted": [
          "January 16, 2015"
        ],
        "study_first_posted": [
          "January 22, 2015"
        ],
        "last_update_submitted": [
          "October 17, 2017"
        ],
        "last_update_posted": [
          "October 19, 2017"
        ],
        "locations": [
          {
            "location": [
              "Alabama CRS, Birmingham, Alabama, United States",
              "University of Arizona CRS, Tucson, Arizona, United States",
              "University of Southern California CRS, Los Angeles, California, United States",
              "UCLA CARE Center CRS, Los Angeles, California, United States",
              "Mills Clinical Research CRS, Los Angeles, California, United States",
              "VA West Los Angeles Medical Center CRS, Los Angeles, California, United States",
              "Los Angeles LGBT Center CRS, Los Angeles, California, United States",
              "Eisenhower Health Center at Rimrock CRS, Palm Springs, California, United States",
              "Stanford AIDS Clinical Trials Unit CRS, Palo Alto, California, United States",
              "UCSD Antiviral Research Center CRS, San Diego, California, United States",
              "Ucsf Hiv/Aids Crs, San Francisco, California, United States",
              "Harbor-UCLA CRS, Torrance, California, United States",
              "University of Colorado Hospital CRS, Aurora, Colorado, United States",
              "Denver Public Health CRS, Denver, Colorado, United States",
              "Yale University CRS, New Haven, Connecticut, United States",
              "VA Connecticut Healthcare System CRS, West Haven, Connecticut, United States",
              "Whitman-Walker Health CRS, Washington, D.C., District of Columbia, United States",
              "Georgetown University CRS (GU CRS), Washington, D.C., District of Columbia, United States",
              "Capital Medical Associates, PC CRS, Washington, D.C., District of Columbia, United States",
              "Infectious Diseases Clinic, Washington DC Veterans Affairs Medical Center CRS, Washington, D.C., District of Columbia, United States",
              "Malcom Randall VA Medical Center CRS, Gainesville, Florida, United States",
              "University of Florida Clinical Research Center CRS, Gainesville, Florida, United States",
              "AHF-The Kinder Medical Group CRS, Miami, Florida, United States",
              "The University of Miami AIDS Clinical Research Unit (ACRU) CRS, Miami, Florida, United States",
              "University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS, Miami, Florida, United States",
              "AHF - South Beach CRS, Miami, Florida, United States",
              "Orlando Immunology Center CRS, Orlando, Florida, United States",
              "Sunshine Care Center CRS, Orlando, Florida, United States",
              "Community AIDS Network/Comprehensive Care Clinic CRS, Sarasota, Florida, United States",
              "Florida Department of Health - Hillsborough County, Tampa, Florida, United States",
              "AIDS Research and Treatment Center of the Treasure Coast CRS, Vero Beach, Florida, United States",
              "The Ponce de Leon Center CRS, Atlanta, Georgia, United States",
              "Augusta University Research Institute, Inc. CRS, Augusta, Georgia, United States",
              "Northwestern University CRS, Chicago, Illinois, United States",
              "Rush University CRS, Chicago, Illinois, United States",
              "UIC Project WISH CRS, Chicago, Illinois, United States",
              "Indiana University Infectious Diseases Research CRS, Indianapolis, Indiana, United States",
              "Department of Internal Medicine, University of Iowa Hospitals & Clinics CRS, Iowa City, Iowa, United States",
              "Bluegrass Care Clinic/University of Kentucky Research Foundation CRS, Lexington, Kentucky, United States",
              "550 Clinic -University of Louisville CRS, Louisville, Kentucky, United States",
              "Tulane - Louisiana Community AIDS Research Program (T-LaCARP) CRS, New Orleans, Louisiana, United States",
              "University of Maryland Baltimore, Institute of Human Virology CRS, Baltimore, Maryland, United States",
              "Johns Hopkins University CRS, Baltimore, Maryland, United States",
              "Tufts Medical Center CRS, Boston, Massachusetts, United States",
              "Massachusetts General Hospital CRS (MGH CRS), Boston, Massachusetts, United States",
              "Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS, Boston, Massachusetts, United States",
              "Boston Medical Center CRS, Boston, Massachusetts, United States",
              "Baystate Infectious Diseases Clinical Research CRS, Springfield, Massachusetts, United States",
              "Henry Ford Hosp. CRS, Detroit, Michigan, United States",
              "St. John Newland Medical Associates CRS, Southfield, Michigan, United States",
              "Abbott Northwestern Hospital CRS, Minneapolis, Minnesota, United States",
              "University of Mississippi Medical Center CRS, Jackson, Mississippi, United States",
              "Washington University Therapeutics (WT) CRS, Saint Louis, Missouri, United States",
              "Southampton Healthcare, Inc. CRS, Saint Louis, Missouri, United States",
              "Specialty Care Center CRS, Omaha, Nebraska, United States",
              "Cooper Univ. Hosp. CRS, Camden, New Jersey, United States",
              "New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States",
              "Albany Medical College CRS, Albany, New York, United States",
              "VA New York Harbor Healthcare System (NYHHS), Brooklyn Campus CRS, Brooklyn, New York, United States",
              "Mount Sinai Beth Israel CRS, New York, New York, United States",
              "VA New York Harbor Healthcare System (NYHHS), NY Campus CRS, New York, New York, United States",
              "Weill Cornell Chelsea CRS, New York, New York, United States",
              "Mount Sinai Downtown CRS, New York, New York, United States",
              "Mount Sinai St. Luke's West 17 St. CRS, New York, New York, United States",
              "Mount Sinai West Samuels CRS, New York, New York, United States",
              "Mount Sinai St. Luke's Morningside CRS, New York, New York, United States",
              "Infectious Disease Clinical and Translational Research Center (CTRC) CRS, New York, New York, United States",
              "Columbia P&S CRS, New York, New York, United States",
              "Weill Cornell Uptown CRS, New York, New York, United States",
              "University of Rochester Adult HIV Therapeutic Strategies Network CRS, Rochester, New York, United States",
              "James J Peters VA Medical Center CRS, The Bronx, New York, United States",
              "Chapel Hill CRS, Chapel Hill, North Carolina, United States",
              "Duke University Medical Center CRS, Durham, North Carolina, United States",
              "Greensboro CRS, Greensboro, North Carolina, United States",
              "Wake Forest Baptist Medical Center CRS, Winston-Salem, North Carolina, United States",
              "Cincinnati Clinical Research Site, Cincinnati, Ohio, United States",
              "Case Clinical Research Site, Cleveland, Ohio, United States",
              "Ohio State University CRS, Columbus, Ohio, United States",
              "University of Toledo Medical Center CRS, Toledo, Ohio, United States",
              "Oklahoma State University Center for Health Sciences CRS, Tulsa, Oklahoma, United States",
              "Division of Infectious Diseases Clinical Research Center- Drexel University CRS, Philadelphia, Pennsylvania, United States",
              "Penn Therapeutics, CRS, Philadelphia, Pennsylvania, United States",
              "Center of Translational AIDS Research, Lewis Katz School of Medicine at Temple University CRS, Philadelphia, Pennsylvania, United States",
              "Positive Health Clinic CRS, Pittsburgh, Pennsylvania, United States",
              "University of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States",
              "The Miriam Hospital Clinical Research Site (TMH CRS) CRS, Providence, Rhode Island, United States",
              "Medical University of South Carolina: Division of Infectious Diseases CRS, Charleston, South Carolina, United States",
              "Palmetto Health Clinical Trial Department CRS, Columbia, South Carolina, United States",
              "Vanderbilt Therapeutics (VT) CRS, Nashville, Tennessee, United States",
              "Trinity Health and Wellness Center CRS, Dallas, Texas, United States",
              "Dallas VA Medical Center CRS, Dallas, Texas, United States",
              "UT Southwestern HIV/ID Clinical Trials Unit CRS, Dallas, Texas, United States",
              "Houston AIDS Research Team CRS, Houston, Texas, United States",
              "Michael E. DeBakey VAMC REPRIEVE CRS, Houston, Texas, United States",
              "Inova Heart and Vascular Institute CRS, Falls Church, Virginia, United States",
              "Virginia Commonwealth University CRS, Richmond, Virginia, United States",
              "University of Washington AIDS CRS, Seattle, Washington, United States",
              "Medical College of Wisconsin, Inc. CRS, Milwaukee, Wisconsin, United States",
              "Gaborone CRS, Gaborone, South-East District, Botswana",
              "Tropical Medicine Foundation Dr. Heitor Vieira Dourado CRS, Manaus, Amazonas, Brazil",
              "School of Medicine, Federal University of Minas Gerais CRS, Belo Horizonte, Minas Gerais, Brazil",
              "HGNI HIV Family Care Clinic - HHFCC CRS, Nova Iguacu, Rio de Janeiro, Brazil",
              "Hospital Nossa Senhora da Conceicao CRS, Porto Alegre, Rio Grande do Sul, Brazil",
              "Centro de Referencia e Treinamento DST/AIDS CRS, Sao Paulo, São Paulo, Brazil",
              "Projeto Praça Onze Pesquisa em Saúde CRS, Rio de Janeiro, Brazil",
              "Hospital Federal dos Servidores do Estado CRS, Rio de Janeiro, Brazil",
              "Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro, Brazil",
              "Instituto de Infectologia Emilio Ribas CRS, Sao Paulo, Brazil",
              "Centro de Pesquisas Clínicas IC-HCFMUSP CRS, Sao Paulo, Brazil",
              "Vancouver ID Research & Care Centre Society CRS, Vancouver, British Columbia, Canada",
              "Hamilton Health Sciences - Special Immunology Services Clinic CRS, Hamilton, Ontario, Canada",
              "Maple Leaf Research CRS, Toronto, Ontario, Canada",
              "Toronto General Hospital CRS, Toronto, Ontario, Canada",
              "Clinique Medicale L'Actuel CRS, Montreal, Quebec, Canada",
              "Chronic Viral Illness Service CRS, Montreal, Quebec, Canada",
              "Centre hospitalier de l'Université Laval CRS, Quebec City, Quebec, Canada",
              "Byramjee Jeejeebhoy Medical College (BJMC) CRS, Pune, Maharashtra, India",
              "Chennai Antiviral Research and Treatment (CART) CRS, Chennai, Tamil Nadu, India",
              "Barranco CRS, Lima, Peru",
              "San Miguel CRS, Lima, Peru",
              "Puerto Rico AIDS Clinical Trials Unit CRS, San Juan, Puerto Rico",
              "Soweto ACTG CRS, Johannesburg, Gauteng, South Africa",
              "Wits Helen Joseph Hospital CRS (Wits HJH CRS), Johannesburg, Gauteng, South Africa",
              "Durban International Clinical Research Site CRS, Durban, Kwa Zulu Natal, South Africa",
              "University of Cape Town Lung Institute (UCTLI) CRS, Cape Town, Western Cape Province, South Africa",
              "Fam-Cru Crs, Tygerberg, Western Cape Province, South Africa",
              "Thai Red Cross AIDS Research Centre (TRC-ARC) CRS, Bangkok, Thailand",
              "Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS, Chiang Mai, Thailand"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02344290"
        ]
      },
      {
        "$": {
          "rank": "54"
        },
        "nct_id": [
          "NCT02382471"
        ],
        "title": [
          "Assessing the Effects of Omega-3 Supplementation on Some Serum BDNF، Follistatin، Irisin Levels in Men With CAD"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Omega-3",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Serum Irisin",
              "Serum Brain-Derived Neurotrophic Factor(BDNF)",
              "Serum Follistatin",
              "Serum Myostatin",
              "Serum high-sensitivity C-reactive protein (hsCRP)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Tehran University of Medical Sciences"
            ]
          }
        ],
        "gender": [
          "Male"
        ],
        "min_age": [
          "45 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 4"
            ]
          }
        ],
        "enrollment": [
          "21"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Triple (Participant, Investigator, Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "159753"
            ]
          }
        ],
        "start_date": [
          "December 2011"
        ],
        "primary_completion_date": [
          "August 2013"
        ],
        "completion_date": [
          "October 2013"
        ],
        "last_verified": [
          "March 2015"
        ],
        "first_received": [
          "February 16, 2015"
        ],
        "last_updated": [
          "March 2, 2015"
        ],
        "study_first_submitted": [
          "February 16, 2015"
        ],
        "study_first_posted": [
          "March 6, 2015"
        ],
        "last_update_submitted": [
          "March 2, 2015"
        ],
        "last_update_posted": [
          "March 6, 2015"
        ],
        "locations": [
          {
            "location": [
              "Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02382471"
        ]
      },
      {
        "$": {
          "rank": "55"
        },
        "nct_id": [
          "NCT02892136"
        ],
        "title": [
          "Technical Development for Pediatric Cardiovascular MRI"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Congenital Heart Disease",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "To evaluate innovative noninvasive MRI techniques suitable for evaluating pediatric patients with cardiovascular disease, congenital cardiac disease, and fetal organ analysis including cardiac structure, function, and physiology.",
              "Natural history of congenital heart disease"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Children's Research Institute"
            ],
            "collaborator": [
              "National Heart, Lung, and Blood Institute (NHLBI)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "5000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "NIH"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "2359",
              "HHSN268201500001C"
            ]
          }
        ],
        "start_date": [
          "May 2013"
        ],
        "primary_completion_date": [
          "May 2026"
        ],
        "completion_date": [
          "December 2026"
        ],
        "last_verified": [
          "September 2016"
        ],
        "first_received": [
          "July 21, 2016"
        ],
        "last_updated": [
          "September 1, 2016"
        ],
        "study_first_submitted": [
          "July 21, 2016"
        ],
        "study_first_posted": [
          "September 8, 2016"
        ],
        "last_update_submitted": [
          "September 1, 2016"
        ],
        "last_update_posted": [
          "September 8, 2016"
        ],
        "locations": [
          {
            "location": [
              "Children's National Health System, Washington, District of Columbia, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02892136"
        ]
      },
      {
        "$": {
          "rank": "56"
        },
        "nct_id": [
          "NCT02903433"
        ],
        "title": [
          "Effects of Avocado Intake on the Nutritional Status of Families"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "High-intake avocados",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Low-intake avocados",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Diet tips",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Avocado consumption advice",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in nutritional status by red blood cell fatty acid composition at 3 months",
              "Change in nutritional status by red blood cell magnesium at 3 months",
              "Change in nutritional status by serum total and fractionated carotenoids at 3 months",
              "Change in nutritional status by red blood cell fatty acid composition at 6 months",
              "Change in nutritional status by red blood cell magnesium at 6 months",
              "Change in nutritional status by serum total and fractionated carotenoids at 6 months",
              "Change in cardio-metabolic risk factors by serum lipids at 3 months",
              "Change in cardio-metabolic risk factors by insulin at 3 months",
              "Change in cardio-metabolic risk factors by glucose at 3 months",
              "Change in cardio-metabolic risk factors by computation of homeostasis model assessment at 3 months",
              "Change in cardio-metabolic risk factors by serum lipids at 6 months",
              "Change in cardio-metabolic risk factors by insulin at 6 months",
              "Change in cardio-metabolic risk factors by glucose at 6 months",
              "Change in cardio-metabolic risk factors by computation of homeostasis model assessment at 6 months"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of California, San Diego"
            ],
            "collaborator": [
              "San Diego State University",
              "San Ysidro Health Center"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "5 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "70"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "160584"
            ]
          }
        ],
        "start_date": [
          "April 20, 2017"
        ],
        "primary_completion_date": [
          "June 2018"
        ],
        "completion_date": [
          "June 2018"
        ],
        "last_verified": [
          "September 2017"
        ],
        "first_received": [
          "September 2, 2016"
        ],
        "last_updated": [
          "September 28, 2017"
        ],
        "study_first_submitted": [
          "September 2, 2016"
        ],
        "study_first_posted": [
          "September 16, 2016"
        ],
        "last_update_submitted": [
          "September 28, 2017"
        ],
        "last_update_posted": [
          "October 2, 2017"
        ],
        "locations": [
          {
            "location": [
              "South Bay Latino Research Center, Chula Vista, California, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02903433"
        ]
      },
      {
        "$": {
          "rank": "57"
        },
        "nct_id": [
          "NCT02556749"
        ],
        "title": [
          "Effects of Cranberry Juice on Cardiovascular Risk Factors"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease Risk Factors"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Cranberry Juice Beverage",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Placebo Beverage",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Central Blood Pressure",
              "Peripheral Blood Pressure",
              "Efflux capacity of HDL",
              "Augmentation Index",
              "Pulse Wave Velocity",
              "LDL-C",
              "LDL Particle Size",
              "Total Cholesterol",
              "Triglycerides",
              "HDL-C",
              "Oxidized LDL (oxLDL)",
              "Malondialdehyde (MDA)",
              "High Sensitivity C Reactive Protein (hs-CRP)",
              "24-hr Ambulatory Blood Pressure"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Penn State University"
            ],
            "collaborator": [
              "Ocean Spray Cranberries, Inc."
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "30 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "50"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "PKE CRAN"
            ]
          }
        ],
        "start_date": [
          "October 2015"
        ],
        "primary_completion_date": [
          "September 2017"
        ],
        "completion_date": [
          "March 2018"
        ],
        "last_verified": [
          "January 2017"
        ],
        "first_received": [
          "September 18, 2015"
        ],
        "last_updated": [
          "January 3, 2017"
        ],
        "study_first_submitted": [
          "September 18, 2015"
        ],
        "study_first_posted": [
          "September 22, 2015"
        ],
        "last_update_submitted": [
          "January 3, 2017"
        ],
        "last_update_posted": [
          "January 4, 2017"
        ],
        "locations": [
          {
            "location": [
              "Penn State CRC, University Park, Pennsylvania, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02556749"
        ]
      },
      {
        "$": {
          "rank": "58"
        },
        "nct_id": [
          "NCT02821780"
        ],
        "title": [
          "CADASIL Disease Discovery"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Arterial Stiffness"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "To study the pathogenesis of CADASIL through comprehensive clinical evaluations and molecular studies on biospecimens collected under this protocol from affected and unaffected cohorts (as reference biospecimens).",
              "Clinical evaluations will be used to determine whether disease progression can be assessed."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "National Heart, Lung, and Blood Institute (NHLBI)"
            ],
            "collaborator": [
              "National Institutes of Health Clinical Center (CC)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "100 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "20"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "NIH"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "160132",
              "16-H-0132"
            ]
          }
        ],
        "start_date": [
          "June 29, 2016"
        ],
        "primary_completion_date": [
          "April 6, 2020"
        ],
        "completion_date": [
          "April 6, 2020"
        ],
        "last_verified": [
          "October 2, 2017"
        ],
        "first_received": [
          "June 29, 2016"
        ],
        "last_updated": [
          "October 18, 2017"
        ],
        "study_first_submitted": [
          "June 29, 2016"
        ],
        "study_first_posted": [
          "July 4, 2016"
        ],
        "last_update_submitted": [
          "October 18, 2017"
        ],
        "last_update_posted": [
          "October 19, 2017"
        ],
        "locations": [
          {
            "location": [
              "National Institutes of Health Clinical Center, Bethesda, Maryland, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02821780"
        ]
      },
      {
        "$": {
          "rank": "59"
        },
        "nct_id": [
          "NCT02367963"
        ],
        "title": [
          "Peer-group-based Intervention Program"
        ],
        "acronym": [
          "Fifty-Fifty"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Training period",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Peer-group",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "The improvement in a newly defined score combining 5 individual variables: the Fuster-BEWAT score",
              "The mean changes in the individual components of the Fuster-BEWAT score and the mean changes in systolic and diastolic blood pressure levels and Body Mass Index and in the habit parameters evaluated using validated questionnaires."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Foundation for Science, Health and Education, Spain"
            ],
            "collaborator": [
              "Spanish Agency for Consumer, Nutrition and Food Safety (AECOSAN).",
              "Nutrition, physical activity and obese prevention Strategy (NAOS)",
              "Spanish federation for municipalities and provinces (FEMP)."
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "25 Years"
        ],
        "max_age": [
          "50 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "543"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "SHE-001-FM"
            ]
          }
        ],
        "start_date": [
          "September 2013"
        ],
        "primary_completion_date": [
          "December 2016"
        ],
        "completion_date": [
          "December 2016"
        ],
        "last_verified": [
          "February 2016"
        ],
        "first_received": [
          "February 12, 2015"
        ],
        "last_updated": [
          "January 24, 2017"
        ],
        "study_first_submitted": [
          "February 12, 2015"
        ],
        "study_first_posted": [
          "February 20, 2015"
        ],
        "last_update_submitted": [
          "January 24, 2017"
        ],
        "last_update_posted": [
          "January 25, 2017"
        ],
        "locations": [
          {
            "location": [
              "Foundation for Science, Health & Education, Madrid, Spain"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02367963"
        ]
      },
      {
        "$": {
          "rank": "60"
        },
        "nct_id": [
          "NCT02981771"
        ],
        "title": [
          "The Effect of Exercise Training Programs On Balance in Older Adults With CVD"
        ],
        "recruitment": [
          {
            "_": "Not yet recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Aging",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Balance activity program",
                "$": {
                  "type": "Behavioral"
                }
              },
              {
                "_": "Strength activity program",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in Balance ability - a composite outcome"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Hillel Yaffe Medical Center"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "50"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "0083-16-HYMC"
            ]
          }
        ],
        "start_date": [
          "December 2016"
        ],
        "primary_completion_date": [
          "December 2017"
        ],
        "last_verified": [
          "November 2016"
        ],
        "first_received": [
          "November 29, 2016"
        ],
        "last_updated": [
          "November 30, 2016"
        ],
        "study_first_submitted": [
          "November 29, 2016"
        ],
        "study_first_posted": [
          "December 5, 2016"
        ],
        "last_update_submitted": [
          "November 30, 2016"
        ],
        "last_update_posted": [
          "December 5, 2016"
        ],
        "locations": [
          {
            "location": [
              "Zinman College for Physical Education and Sport Sciences, Wingate, Israel"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02981771"
        ]
      },
      {
        "$": {
          "rank": "61"
        },
        "nct_id": [
          "NCT02506335"
        ],
        "title": [
          "Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease"
        ],
        "recruitment": [
          {
            "_": "Enrolling by invitation",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Liver Disease",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Cholate testing",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Liver Function"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Northwestern University"
            ],
            "collaborator": [
              "University of Colorado, Denver"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "70 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Early Phase 1"
            ]
          }
        ],
        "enrollment": [
          "10"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Diagnostic"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "STU00100794"
            ]
          }
        ],
        "start_date": [
          "June 2015"
        ],
        "primary_completion_date": [
          "May 2018"
        ],
        "completion_date": [
          "May 2018"
        ],
        "last_verified": [
          "August 2016"
        ],
        "first_received": [
          "June 24, 2015"
        ],
        "last_updated": [
          "August 2, 2016"
        ],
        "study_first_submitted": [
          "June 24, 2015"
        ],
        "study_first_posted": [
          "July 23, 2015"
        ],
        "last_update_submitted": [
          "August 2, 2016"
        ],
        "last_update_posted": [
          "August 3, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02506335"
        ]
      },
      {
        "$": {
          "rank": "62"
        },
        "nct_id": [
          "NCT02987465"
        ],
        "title": [
          "Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease."
        ],
        "acronym": [
          "OPERA-CKD"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases",
              "Chronic Kidney Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Darbepoetin Alfa",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Acetylcholine",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Noradrenaline",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "BQ 123",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Response to intra-arterial acetylcholine",
              "Response to intra-arterial Noradrenaline",
              "Response to intra-arterial BQ123",
              "Change in mean arterial blood pressure",
              "Changes in Arterial stiffness",
              "Correlations between individual challenge agent",
              "Forearm blood flow responses to Acetylcholine, Noradrenaline and BQ123 in patients with CKD compared to healthy volunteers",
              "Responses to Acetylcholine, Noradrenaline and BQ123 in patients with CKD post-Darbepoetin compared to healthy volunteers"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Cambridge University Hospitals NHS Foundation Trust"
            ],
            "collaborator": [
              "GlaxoSmithKline"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "24"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Case-Control",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "OPERA-CKD (AO94224)"
            ]
          }
        ],
        "start_date": [
          "February 20, 2017"
        ],
        "primary_completion_date": [
          "January 2019"
        ],
        "completion_date": [
          "January 2019"
        ],
        "last_verified": [
          "March 2017"
        ],
        "first_received": [
          "November 28, 2016"
        ],
        "last_updated": [
          "March 31, 2017"
        ],
        "study_first_submitted": [
          "November 28, 2016"
        ],
        "study_first_posted": [
          "December 9, 2016"
        ],
        "last_update_submitted": [
          "March 31, 2017"
        ],
        "last_update_posted": [
          "April 4, 2017"
        ],
        "locations": [
          {
            "location": [
              "Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02987465"
        ]
      },
      {
        "$": {
          "rank": "63"
        },
        "nct_id": [
          "NCT02806193"
        ],
        "title": [
          "Global CMR Registry"
        ],
        "acronym": [
          "GCMR"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Cardiovascular Magnetic Resonance Imaging",
                "$": {
                  "type": "Procedure"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Mortality",
              "Heart Failure",
              "Acute myocardial infarction",
              "Cardiac Intervention (Implantable cardioverter-defibrillator or ICD)",
              "Cardiac Intervention (pacemakers)",
              "Cardiac Intervention (cardiac surgery)",
              "Cardiac Intervention (coronary revascularization)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Society for Cardiovascular Magnetic Resonance"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "max_age": [
          "89 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "80000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Time Perspective: Retrospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "SCMR_GRANT_001"
            ]
          }
        ],
        "start_date": [
          "January 2014"
        ],
        "primary_completion_date": [
          "December 2020"
        ],
        "last_verified": [
          "June 2016"
        ],
        "first_received": [
          "June 13, 2016"
        ],
        "last_updated": [
          "June 17, 2016"
        ],
        "study_first_submitted": [
          "June 13, 2016"
        ],
        "study_first_posted": [
          "June 20, 2016"
        ],
        "last_update_submitted": [
          "June 17, 2016"
        ],
        "last_update_posted": [
          "June 20, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02806193"
        ]
      },
      {
        "$": {
          "rank": "64"
        },
        "nct_id": [
          "NCT02502812"
        ],
        "title": [
          "Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Clop F1",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Clop F2",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Innovator",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Composite of plasma pharmacokinetic (PK) parameters: AUC(0 ∞), AUC(0 t) and Cmax",
              "Composite of plasma PK parameters: time of occurrence of Cmax (tmax), percentage of AUC(0 ∞) obtained by extrapolation (%AUCex) and terminal phase half-life (t1/2)",
              "Blood pressure as a measure of safety and tolerability",
              "Pulse rate as a measure of safety and tolerability",
              "Number of subjects with adverse events and serious adverse events",
              "Composite of hematology parameters as a measure of safety",
              "Composite of clinical chemistry parameters as a measure of safety",
              "Composite of urinalysis parameters as measured by dipstick method and microscopic examination"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "GlaxoSmithKline"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 1"
            ]
          }
        ],
        "enrollment": [
          "18"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Basic Science"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "200096"
            ]
          }
        ],
        "start_date": [
          "September 4, 2015"
        ],
        "primary_completion_date": [
          "September 24, 2015"
        ],
        "completion_date": [
          "September 24, 2015"
        ],
        "last_verified": [
          "May 2017"
        ],
        "first_received": [
          "July 9, 2015"
        ],
        "last_updated": [
          "May 3, 2017"
        ],
        "study_first_submitted": [
          "July 9, 2015"
        ],
        "study_first_posted": [
          "July 20, 2015"
        ],
        "last_update_submitted": [
          "May 3, 2017"
        ],
        "last_update_posted": [
          "May 8, 2017"
        ],
        "locations": [
          {
            "location": [
              "GSK Investigational Site, Telangana, India"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02502812"
        ]
      },
      {
        "$": {
          "rank": "65"
        },
        "nct_id": [
          "NCT02515578"
        ],
        "title": [
          "Southwest Health Extension Partnership to Enhance Research Dissemination"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Enhanced practice transformation support",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Standard practice transformation support",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change of documentation of aspirin therapy in patients with ischemic vascular disease.",
              "Change of documentation of blood pressure in patients with a diagnosis of hypertension.",
              "Change of documentation of blood pressure in patients with adequately controlled blood pressure.",
              "Change of documentation of fasting LDL in patients with a fasting LDL at or below the LDL goal.",
              "Change of documentation of patients who had a fasting LDL test performed and prescribed a statin based on risk.",
              "Change of documentation of patients screened about tobacco use.",
              "Change of the documentation in primary care practice's."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Colorado, Denver"
            ],
            "collaborator": [
              "University of New Mexico"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "89 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "10000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Health Services Research"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "15-0403"
            ]
          }
        ],
        "start_date": [
          "October 2015"
        ],
        "primary_completion_date": [
          "October 2017"
        ],
        "completion_date": [
          "January 2018"
        ],
        "last_verified": [
          "August 2017"
        ],
        "first_received": [
          "July 15, 2015"
        ],
        "last_updated": [
          "August 29, 2017"
        ],
        "study_first_submitted": [
          "July 15, 2015"
        ],
        "study_first_posted": [
          "August 5, 2015"
        ],
        "last_update_submitted": [
          "August 29, 2017"
        ],
        "last_update_posted": [
          "August 31, 2017"
        ],
        "locations": [
          {
            "location": [
              "University of Colorado, Denver, Denver, Colorado, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02515578"
        ]
      },
      {
        "$": {
          "rank": "66"
        },
        "nct_id": [
          "NCT02518399"
        ],
        "title": [
          "Chronic Heat Therapy for Improving Vascular Health"
        ],
        "acronym": [
          "CHT"
        ],
        "recruitment": [
          {
            "_": "Unknown status",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Heat therapy",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Thermoneutral water immersion",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in flow-mediated dilation",
              "Femoral dynamic arterial compliance",
              "Intima media thickness",
              "Mean arterial blood pressure",
              "Cutaneous nitric oxide-dependent dilation"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Oregon"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "40 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "20"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "09272013.025",
              "14PRE20380300"
            ]
          }
        ],
        "start_date": [
          "April 2013"
        ],
        "primary_completion_date": [
          "September 2015"
        ],
        "last_verified": [
          "August 2015"
        ],
        "first_received": [
          "July 23, 2015"
        ],
        "last_updated": [
          "August 4, 2015"
        ],
        "study_first_submitted": [
          "July 23, 2015"
        ],
        "study_first_posted": [
          "August 7, 2015"
        ],
        "last_update_submitted": [
          "August 4, 2015"
        ],
        "last_update_posted": [
          "August 7, 2015"
        ],
        "locations": [
          {
            "location": [
              "University of Oregon, Eugene, Oregon, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02518399"
        ]
      },
      {
        "$": {
          "rank": "67"
        },
        "nct_id": [
          "NCT02988531"
        ],
        "title": [
          "Validation of PET-MRI for Cardiovascular Disease"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "MRI",
              "PET Scan",
              "Positron-Emission Tomography",
              "Cardiovascular Disease",
              "Coronary Artery Disease",
              "Magnetic Resonance Imaging"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "PET/MR scan",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "The standard uptake values (SUV's) of volumes of interest (VOI's) on corresponding PET-CT and PET-MR images will be evaluated by expert. The distribution of PET positive VOI's will be compared using a cut-off of 1.6 for tissue to background ratio (TBR).",
              "Standard breath-held MR-based attenuation correction will be compared to a novel free-breathing approach. Impact on PET image artifacts and the interpretation of vascular uptake will be evaluated semi-quantitatively by expert readers."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Edinburgh"
            ],
            "collaborator": [
              "British Heart Foundation"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "50 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "20"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Diagnostic"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "AC16105"
            ]
          }
        ],
        "start_date": [
          "February 9, 2017"
        ],
        "primary_completion_date": [
          "June 30, 2017"
        ],
        "completion_date": [
          "June 30, 2017"
        ],
        "last_verified": [
          "September 2016"
        ],
        "first_received": [
          "September 23, 2016"
        ],
        "last_updated": [
          "May 2, 2017"
        ],
        "study_first_submitted": [
          "September 23, 2016"
        ],
        "study_first_posted": [
          "December 9, 2016"
        ],
        "last_update_submitted": [
          "May 2, 2017"
        ],
        "last_update_posted": [
          "May 5, 2017"
        ],
        "locations": [
          {
            "location": [
              "University of Edinburgh, Edinburgh, Lothian, United Kingdom",
              "University of Edinburgh, Edinburgh, Lothian, United Kingdom"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02988531"
        ]
      },
      {
        "$": {
          "rank": "68"
        },
        "nct_id": [
          "NCT02783989"
        ],
        "title": [
          "Effects on Cardiovascular Risk Factors of the Endogenous Hydroxytyrosol Generation After the Combined Intake of Wine and Tyrosol in Humans"
        ],
        "acronym": [
          "DOPET3"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "white wine",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "tyrosol",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Metabolic: changes in hydroxytyrosol generation",
              "Vascular effects: changes in endothelial function",
              "Metabolic effects (n=12)",
              "changes in glucose profile",
              "changes in lipid profile",
              "changes in oxidation profile",
              "changes in oxidation profile (in antioxidant enzymes)",
              "changes in inflammation enzymes",
              "change in endothelial function",
              "Alcohol biomarker",
              "Gene expression"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Parc de Salut Mar"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "50 Years"
        ],
        "max_age": [
          "80 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "60"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Basic Science"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "IMIMFTCLFT/DOPET/3"
            ]
          }
        ],
        "start_date": [
          "January 20, 2016"
        ],
        "primary_completion_date": [
          "December 31, 2017"
        ],
        "completion_date": [
          "June 2018"
        ],
        "last_verified": [
          "February 2017"
        ],
        "first_received": [
          "May 11, 2016"
        ],
        "last_updated": [
          "February 9, 2017"
        ],
        "study_first_submitted": [
          "May 11, 2016"
        ],
        "study_first_posted": [
          "May 26, 2016"
        ],
        "last_update_submitted": [
          "February 9, 2017"
        ],
        "last_update_posted": [
          "February 10, 2017"
        ],
        "locations": [
          {
            "location": [
              "IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02783989"
        ]
      },
      {
        "$": {
          "rank": "69"
        },
        "nct_id": [
          "NCT02576067"
        ],
        "title": [
          "Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study"
        ],
        "acronym": [
          "CIRT"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Vascular Inflammation",
              "Atherosclerotic Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Low dose methotrexate",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in arterial inflammation",
              "Change in max target-to-background (TBR)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Icahn School of Medicine at Mount Sinai"
            ],
            "collaborator": [
              "Brigham and Women's Hospital",
              "Massachusetts General Hospital",
              "St. Michael's Hospital, Toronto",
              "National Institutes of Health (NIH)",
              "National Heart, Lung, and Blood Institute (NHLBI)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 3"
            ]
          }
        ],
        "enrollment": [
          "216"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "NIH"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Double (Participant, Investigator)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "GCO 14-1382",
              "1R01HL128056-01A1"
            ]
          }
        ],
        "start_date": [
          "December 2015"
        ],
        "primary_completion_date": [
          "May 2019"
        ],
        "completion_date": [
          "May 2019"
        ],
        "last_verified": [
          "September 2017"
        ],
        "first_received": [
          "October 13, 2015"
        ],
        "last_updated": [
          "September 26, 2017"
        ],
        "study_first_submitted": [
          "October 13, 2015"
        ],
        "study_first_posted": [
          "October 15, 2015"
        ],
        "last_update_submitted": [
          "September 26, 2017"
        ],
        "last_update_posted": [
          "September 28, 2017"
        ],
        "locations": [
          {
            "location": [
              "Massachusetts General Hospital, Boston, Massachusetts, United States",
              "Icahn School of Medicine at Mount Sinai, New York, New York, United States",
              "St. Michael's Hospital, Toronto, Ontario, Canada"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02576067"
        ]
      },
      {
        "$": {
          "rank": "70"
        },
        "nct_id": [
          "NCT02725203"
        ],
        "title": [
          "Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Activate",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "level of physical activity measured with the Personal Activity Monitor (PAM AM300)",
              "Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS)",
              "Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS)",
              "Patient activation using the Patient Activation Measure (PAM-13)",
              "Health status using the EQ-5D"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "UMC Utrecht"
            ],
            "collaborator": [
              "ZonMw: The Netherlands Organisation for Health Research and Development"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "75 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "297"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Supportive Care"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "NL54286.041.15"
            ]
          }
        ],
        "start_date": [
          "March 2016"
        ],
        "primary_completion_date": [
          "October 2017"
        ],
        "completion_date": [
          "October 2017"
        ],
        "last_verified": [
          "May 2017"
        ],
        "first_received": [
          "March 25, 2016"
        ],
        "last_updated": [
          "May 5, 2017"
        ],
        "study_first_submitted": [
          "March 25, 2016"
        ],
        "study_first_posted": [
          "March 31, 2016"
        ],
        "last_update_submitted": [
          "May 5, 2017"
        ],
        "last_update_posted": [
          "May 9, 2017"
        ],
        "locations": [
          {
            "location": [
              "GP Lienderweg, Asten, Brabant, Netherlands",
              "GP Timmerman, Drunen, Brabant, Netherlands",
              "GP Emmers, s Hertogenbosch, Brabant, Netherlands",
              "GP Klaar and Vincent, Ede, Gelderland, Netherlands",
              "GP Parklaan, Hoevelaken, Gelderland, Netherlands",
              "GP Buren, Buren, Gerlderland, Netherlands",
              "GP Seinhorst, Hilversum, Noord Holland, Netherlands",
              "GP Tjin a Ton and Parlevliet, Amstelveen, Noord-Holland, Netherlands",
              "GP De Kennemerpoort, Bennebroek, Noord-Holland, Netherlands",
              "GP Odijk-Visser, Heerhugowaard, Noord-Holland, Netherlands",
              "GP Munster, Heerhugowaard, Noord-Holland, Netherlands",
              "GP Eedenburgh, Hilversum, Noord-Holland, Netherlands",
              "GP Koedijk, Koedijk, Noord-Holland, Netherlands",
              "GP De Hollenhorst, Nieuw Vennep, Noord-Holland, Netherlands",
              "GP Spelt, Wassenaar, Noord-Holland, Netherlands",
              "GP Jonker, Colmschate, Overijssel, Netherlands",
              "GP Amarant, Kampen, Overijssel, Netherlands",
              "GP Rosing and Bruins Slot, Markelo, Overijssel, Netherlands",
              "GP Blanker, Thiele, Brand, Zwolle, Overijssel, Netherlands",
              "GP Provostlaan, Bilthoven, Utrecht, Netherlands",
              "GP van Steenis, Bunnik, Utrecht, Netherlands",
              "GP De Bilt, De BIlt, Utrecht, Netherlands",
              "GP Tolgaarde, Leusden, Utrecht, Netherlands",
              "GP Odijk, Odijk, Utrecht, Netherlands",
              "GP De Schans, Woudenberg, Utrecht, Netherlands",
              "GP Sparreboom, Alphen aan den Rijn, Zuid-Holland, Netherlands",
              "GP Wiechen, Boskoop, Zuid-Holland, Netherlands",
              "GP De Wiel, Schoonrewoerd, Zuid-Holland, Netherlands",
              "GP Mozaiek, The Hague, Zuid-Holland, Netherlands",
              "GP Loudon, The Hague, Zuid-Holland, Netherlands",
              "GP Lombok, Utrecht, Netherlands"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02725203"
        ]
      },
      {
        "$": {
          "rank": "71"
        },
        "nct_id": [
          "NCT02970604"
        ],
        "title": [
          "PPARGC1β and CNTN4 Genotype Aspirin Study"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Aspirin",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Urinary Thromboxane B2/Creatinine Ratio"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Royal College of Surgeons, Ireland"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 4"
            ]
          }
        ],
        "enrollment": [
          "160"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Diagnostic"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "RCSIMCT20152017"
            ]
          }
        ],
        "start_date": [
          "May 2016"
        ],
        "primary_completion_date": [
          "February 2018"
        ],
        "completion_date": [
          "February 2018"
        ],
        "last_verified": [
          "November 2016"
        ],
        "first_received": [
          "November 18, 2016"
        ],
        "last_updated": [
          "November 18, 2016"
        ],
        "study_first_submitted": [
          "November 18, 2016"
        ],
        "study_first_posted": [
          "November 22, 2016"
        ],
        "last_update_submitted": [
          "November 18, 2016"
        ],
        "last_update_posted": [
          "November 22, 2016"
        ],
        "locations": [
          {
            "location": [
              "Royal College of Surgeons in Ireland, Dublin, Ireland"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02970604"
        ]
      },
      {
        "$": {
          "rank": "72"
        },
        "nct_id": [
          "NCT02459132"
        ],
        "title": [
          "High-Intensity Aerobic Interval Training in Testicular Cancer Survivors"
        ],
        "acronym": [
          "HIITTS"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases",
              "Testicular Neoplasms"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "High-intensity aerobic interval exercise",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Peak aerobic capacity (relative VO2peak)",
              "Peak aerobic capacity (absolute VO2peak)",
              "Postexercise 1-minute heart rate recovery",
              "Heart rate",
              "Systolic blood pressure",
              "Diastolic blood pressure",
              "Respiratory sinus arrhythmia",
              "Average carotid intima-media thickness",
              "Maximal carotid intima-media thickness",
              "Carotid distensibility",
              "Carotid diameter",
              "Brachial flow-mediated dilation",
              "Brachial diameter",
              "Velocity time integral",
              "Shear stress during reactive hyperemia",
              "Carotid-femoral pulse wave velocity",
              "Femoral-toe pulse wave velocity",
              "Fibrinogen",
              "High-sensitivity C-reactive protein",
              "Total cholesterol",
              "High-density lipoprotein",
              "Low-density lipoprotein",
              "Total cholesterol : high-density lipoprotein ratio",
              "Triglycerides",
              "Fasting glucose",
              "Testosterone",
              "Framingham Risk Score",
              "Vascular age",
              "Modifiable CVD Risk Factor Score"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Alberta"
            ]
          }
        ],
        "gender": [
          "Male"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "80 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "63"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Single (Outcomes Assessor)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "HREBA.CC-14-0183"
            ]
          }
        ],
        "start_date": [
          "July 2015"
        ],
        "primary_completion_date": [
          "September 2016"
        ],
        "completion_date": [
          "April 2017"
        ],
        "last_verified": [
          "September 2016"
        ],
        "first_received": [
          "May 21, 2015"
        ],
        "last_updated": [
          "April 20, 2017"
        ],
        "study_first_submitted": [
          "May 21, 2015"
        ],
        "study_first_posted": [
          "June 1, 2015"
        ],
        "last_update_submitted": [
          "April 20, 2017"
        ],
        "last_update_posted": [
          "April 21, 2017"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02459132"
        ]
      },
      {
        "$": {
          "rank": "73"
        },
        "nct_id": [
          "NCT02368418"
        ],
        "title": [
          "China Rural Health Initiative Follow up Study"
        ],
        "acronym": [
          "CRHIFU"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "PCP",
                "$": {
                  "type": "Procedure"
                }
              },
              {
                "_": "SRS",
                "$": {
                  "type": "Procedure"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "mean systolic blood pressure level among all participants and those at high risk",
              "Proportion of individuals regularly visiting the village clinic among all participants and high-risk patients",
              "Proportion of individuals receiving lifestyle advice among all participants and high-risk patients",
              "Proportion of individuals treated with a blood pressure lowering agent among all participants and high-risk patients",
              "Proportion of individuals treated with aspirin among all participants and high-risk patients",
              "Proportion of individuals having knowledge on salt reduction among all participants and high-risk patients",
              "Proportion of individuals using low sodium salt among all participants and high-risk patients",
              "Proportion of individuals adopting healthy behavior among all participants and high-risk patients",
              "Proportion of individuals developing CVD event among all participants and high-risk patients"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "The George Institute for Global Health, China"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "50 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "9164"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "PKU00001052"
            ]
          }
        ],
        "start_date": [
          "September 2014"
        ],
        "primary_completion_date": [
          "February 2016"
        ],
        "completion_date": [
          "August 2016"
        ],
        "last_verified": [
          "January 2016"
        ],
        "first_received": [
          "September 2, 2014"
        ],
        "last_updated": [
          "February 23, 2017"
        ],
        "study_first_submitted": [
          "September 2, 2014"
        ],
        "study_first_posted": [
          "February 23, 2015"
        ],
        "last_update_submitted": [
          "February 23, 2017"
        ],
        "last_update_posted": [
          "February 27, 2017"
        ],
        "locations": [
          {
            "location": [
              "Hebei Province Center for Disease Prevention and Control ,China, Shijiazhuang, Hebei, China",
              "The First Hospital Of China Medical University, Shenyang, Liaoning, China",
              "Ningxia Medical University School of Public Health, Yinchuan, Ningxia, China",
              "Xi'an Jiaotong University, Xi'an, Shaanxi, China",
              "Changzhi Medical College, China, Changzhi, Shanxi, China"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02368418"
        ]
      },
      {
        "$": {
          "rank": "74"
        },
        "nct_id": [
          "NCT02835547"
        ],
        "title": [
          "Evaluation and Management of Cardiovascular Risk Factors in Inflammatory and Acquired Dysimmune Diseases (CARMIN)"
        ],
        "acronym": [
          "CARMIN"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Inflammatory and Acquired Dysimmune Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Data collection",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "The occurrence of any cardiovascular event (will be recorded from the patient files and/or phone calls to patient\")"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Hospices Civils de Lyon"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "600"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "D50841"
            ]
          }
        ],
        "start_date": [
          "February 2009"
        ],
        "primary_completion_date": [
          "August 2015"
        ],
        "completion_date": [
          "August 2015"
        ],
        "last_verified": [
          "July 2016"
        ],
        "first_received": [
          "June 21, 2016"
        ],
        "last_updated": [
          "July 15, 2016"
        ],
        "study_first_submitted": [
          "June 21, 2016"
        ],
        "study_first_posted": [
          "July 18, 2016"
        ],
        "last_update_submitted": [
          "July 15, 2016"
        ],
        "last_update_posted": [
          "July 18, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02835547"
        ]
      },
      {
        "$": {
          "rank": "75"
        },
        "nct_id": [
          "NCT02813642"
        ],
        "title": [
          "Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Chronic Kidney Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Plasma osteoprotegerin level",
                "$": {
                  "type": "Biological"
                }
              },
              {
                "_": "Plasma fibroblast growth factor 23 level",
                "$": {
                  "type": "Biological"
                }
              },
              {
                "_": "Vascular calcification score",
                "$": {
                  "type": "Procedure"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Progression of vascular calcifications during a 2 year follow up according to plasma osteoprotegerin level at inclusion",
              "Progression of vascular calcifications during a 2 year follow up according to plasma fibroblast growth factor 23 level at inclusion",
              "Occurence of cardiovascular events during a 2 year follow up"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University Hospital, Montpellier"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "90 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "400"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Supportive Care"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "UF8851"
            ]
          }
        ],
        "start_date": [
          "December 2011"
        ],
        "primary_completion_date": [
          "November 2017"
        ],
        "completion_date": [
          "November 2018"
        ],
        "last_verified": [
          "January 2017"
        ],
        "first_received": [
          "June 20, 2016"
        ],
        "last_updated": [
          "January 17, 2017"
        ],
        "study_first_submitted": [
          "June 20, 2016"
        ],
        "study_first_posted": [
          "June 27, 2016"
        ],
        "last_update_submitted": [
          "January 17, 2017"
        ],
        "last_update_posted": [
          "January 18, 2017"
        ],
        "locations": [
          {
            "location": [
              "Centre Hémodialyse du Lez, Castelnau Le Lez, France",
              "AIDER, Montpellier, France",
              "CHU Montpellier, Nephrology department, Montpellier, France",
              "CH Nimes, Nephrology department, Nimes, France",
              "CH Perpignan, Nephrology department, Perpignan, France"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02813642"
        ]
      },
      {
        "$": {
          "rank": "76"
        },
        "nct_id": [
          "NCT02901860"
        ],
        "title": [
          "Shift Work and Risk of Cardio-vascular Disease"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Shift-Work Sleep Disorder"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Sleep, Dietary and Cardio-metabolic Measurements",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "cardio-metabolic risk",
              "Obesity"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Chicago"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "86"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Case Control",
              "Time Perspective: Cross-Sectional"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "11-0725"
            ]
          }
        ],
        "start_date": [
          "January 2012"
        ],
        "primary_completion_date": [
          "December 2014"
        ],
        "completion_date": [
          "December 2014"
        ],
        "last_verified": [
          "September 2016"
        ],
        "first_received": [
          "July 25, 2016"
        ],
        "last_updated": [
          "September 30, 2016"
        ],
        "study_first_submitted": [
          "July 25, 2016"
        ],
        "study_first_posted": [
          "September 15, 2016"
        ],
        "last_update_submitted": [
          "September 30, 2016"
        ],
        "last_update_posted": [
          "October 3, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02901860"
        ]
      },
      {
        "$": {
          "rank": "77"
        },
        "nct_id": [
          "NCT02820870"
        ],
        "title": [
          "Quality Improvement and Personalization for Statins"
        ],
        "acronym": [
          "QUIPS"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Statin Decision Support Intervention",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Pre/post change in the % of patients meeting the VA/DoD Cholesterol Guidelines",
              "Percentage of providers who adopt the VA/DoD Cholesterol Guidelines",
              "Change in provider knowledge of the VA/DoD Guidelines",
              "Change in provider satisfaction with the VA/DoD Guidelines",
              "Frequency of statin discussions between providers and patients",
              "Quality and consistency with which the guidelines were followed",
              "Provider assessment form return",
              "Patient assessment form return"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "VA Office of Research and Development"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "99 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "15"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "U.S. Fed"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Health Services Research"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "QUX 16-002",
              "QUE 15-286"
            ]
          }
        ],
        "start_date": [
          "March 2016"
        ],
        "primary_completion_date": [
          "August 2016"
        ],
        "completion_date": [
          "October 1, 2016"
        ],
        "last_verified": [
          "June 2017"
        ],
        "first_received": [
          "May 23, 2016"
        ],
        "last_updated": [
          "June 12, 2017"
        ],
        "study_first_submitted": [
          "May 23, 2016"
        ],
        "study_first_posted": [
          "July 1, 2016"
        ],
        "last_update_submitted": [
          "June 12, 2017"
        ],
        "last_update_posted": [
          "June 14, 2017"
        ],
        "locations": [
          {
            "location": [
              "VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02820870"
        ]
      },
      {
        "$": {
          "rank": "78"
        },
        "nct_id": [
          "NCT02585089"
        ],
        "title": [
          "Effects of Cured Pork Peptides on Blood Pressure & Cardiovascular Risk Factors"
        ],
        "acronym": [
          "PocPep-CVD"
        ],
        "recruitment": [
          {
            "_": "Active, not recruiting",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Hypertension",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Spanish cured-pork ham",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Cooked pork ham",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change from Baseline in Systolic Blood Pressure at 28 days"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Universidad Católica San Antonio de Murcia"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "35 Years"
        ],
        "max_age": [
          "60 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "50"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Single (Participant)",
              "Primary Purpose: Supportive Care"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "UCAM-BACCHUS"
            ]
          }
        ],
        "start_date": [
          "October 2015"
        ],
        "primary_completion_date": [
          "April 2016"
        ],
        "completion_date": [
          "September 2016"
        ],
        "last_verified": [
          "July 2016"
        ],
        "first_received": [
          "July 31, 2015"
        ],
        "last_updated": [
          "July 25, 2016"
        ],
        "study_first_submitted": [
          "July 31, 2015"
        ],
        "study_first_posted": [
          "October 23, 2015"
        ],
        "last_update_submitted": [
          "July 25, 2016"
        ],
        "last_update_posted": [
          "July 26, 2016"
        ],
        "locations": [
          {
            "location": [
              "Catholic University of Murcia (UCAM), Murcia, Spain"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02585089"
        ]
      },
      {
        "$": {
          "rank": "79"
        },
        "nct_id": [
          "NCT02972619"
        ],
        "title": [
          "Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health"
        ],
        "recruitment": [
          {
            "_": "Not yet recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Hypertension",
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Structured Multicomponent Intervention (MCI)",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in Systolic Blood Pressure from baseline to final follow-up at 24 months",
              "Change in serum LDL from baseline to final follow-up at 24 months",
              "Proportion of hypertensive individuals with BP controlled to target or > 5 mm Hg decrease in systolic BP",
              "Proportion of hypertensive individuals with decrease in LDL cholesterol by >0.4 mmol/L (>15 mg/dl).",
              "Composite outcome of death or hospital admission due to Coronary heart disease (CHD), heart failure, or stroke",
              "Individual outcomes of all-cause mortality, Cardiovascular disease (CVD) deaths, and hospital admission due to CHD, heart failure, or stroke",
              "Decrease of > 0.5 percent in glycated hemoglobin or change in proportion of hypertensive individuals with glycated hemoglobin <7% in hypertensive individuals with diabetes",
              "Change in albuminuria from baseline to follow-up at 24 months",
              "Change in estimated CKD-EPI GFR from baseline to follow-up at 24 months",
              "Change in cardiovascular disease (CVD) risk score",
              "Individual outcomes of change in a) diastolic BP and b) total cholesterol from baseline to end of follow-up at 24 months",
              "Change in lifestyle (diet, physical activity based on self-report) or BMI between groups",
              "Change in systolic blood pressure from baseline to 12 months",
              "Change in serum LDL cholesterol from baseline to 12 months"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Duke-NUS Graduate Medical School"
            ],
            "collaborator": [
              "SingHealth Polyclinics"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "1000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Health Services Research"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "NMRC/CSA-SI/0005/2015"
            ]
          }
        ],
        "start_date": [
          "December 2016"
        ],
        "primary_completion_date": [
          "April 2019"
        ],
        "completion_date": [
          "April 2019"
        ],
        "last_verified": [
          "November 2016"
        ],
        "first_received": [
          "November 20, 2016"
        ],
        "last_updated": [
          "November 21, 2016"
        ],
        "study_first_submitted": [
          "November 20, 2016"
        ],
        "study_first_posted": [
          "November 23, 2016"
        ],
        "last_update_submitted": [
          "November 21, 2016"
        ],
        "last_update_posted": [
          "November 23, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02972619"
        ]
      },
      {
        "$": {
          "rank": "80"
        },
        "nct_id": [
          "NCT02330224"
        ],
        "title": [
          "Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Hypertension",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Hypertension Management Intervention",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in Systolic Blood Pressure from baseline to final follow-up at 3 months",
              "Proportion of planned orientation sessions delivered",
              "Percent uptake of motivational interviewing sessions",
              "Percent of data (laboratory and medication) retrieved from the polyclinic electronic database",
              "Proportion of blood pressure readings obtained at final follow-up",
              "Proportion of participants recruited"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Duke-NUS Graduate Medical School"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "100"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Non-Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Health Services Research"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "2013/663/E"
            ]
          }
        ],
        "start_date": [
          "July 2014"
        ],
        "primary_completion_date": [
          "December 2014"
        ],
        "completion_date": [
          "December 2014"
        ],
        "last_verified": [
          "December 2014"
        ],
        "first_received": [
          "December 28, 2014"
        ],
        "last_updated": [
          "December 31, 2014"
        ],
        "study_first_submitted": [
          "December 28, 2014"
        ],
        "study_first_posted": [
          "January 1, 2015"
        ],
        "last_update_submitted": [
          "December 31, 2014"
        ],
        "last_update_posted": [
          "January 1, 2015"
        ],
        "locations": [
          {
            "location": [
              "SingHealth Polyclinics, Geylang, Singapore, Singapore",
              "SingHealth Polyclinics, Tampines, Singapore, Singapore"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02330224"
        ]
      },
      {
        "$": {
          "rank": "81"
        },
        "nct_id": [
          "NCT02821104"
        ],
        "title": [
          "Complement and Cardiovascular Risk in Adolescents"
        ],
        "acronym": [
          "CCRIA"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Type 2 Diabetes"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Complement C3 genotype",
              "C4 copy number",
              "Body mass",
              "Waist circumference",
              "Body fat",
              "endothelial function",
              "Vascular stiffness",
              "endothelin 1",
              "inflammation",
              "clotting",
              "insulin sensitivity"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Ohio State University"
            ],
            "collaborator": [
              "American Heart Association"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "12 Years"
        ],
        "max_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "100"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "Peds34"
            ]
          }
        ],
        "start_date": [
          "June 2016"
        ],
        "primary_completion_date": [
          "June 2018"
        ],
        "completion_date": [
          "June 2018"
        ],
        "last_verified": [
          "January 2017"
        ],
        "first_received": [
          "June 29, 2016"
        ],
        "last_updated": [
          "January 11, 2017"
        ],
        "study_first_submitted": [
          "June 29, 2016"
        ],
        "study_first_posted": [
          "July 1, 2016"
        ],
        "last_update_submitted": [
          "January 11, 2017"
        ],
        "last_update_posted": [
          "January 12, 2017"
        ],
        "locations": [
          {
            "location": [
              "Ohio State University, Columbus, Ohio, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02821104"
        ]
      },
      {
        "$": {
          "rank": "82"
        },
        "nct_id": [
          "NCT02620709"
        ],
        "title": [
          "The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians"
        ],
        "acronym": [
          "KaHOLO"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Hypertension"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Hula intervention",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change in participants' systolic blood pressure at each time frame from baseline",
              "Change in participants' Framingham Risk Score of 10 year CVD risk at each time frame from baseline"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Hawaii"
            ],
            "collaborator": [
              "I Ola Lahui, Inc.",
              "Ke Ola Mamo",
              "University of Washington",
              "Hui No Ke Ola Pono, Inc.",
              "Kula No Na Po'e Hawaii"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "21 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "250"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "KaHOLO Project"
            ]
          }
        ],
        "start_date": [
          "January 2016"
        ],
        "primary_completion_date": [
          "September 2019"
        ],
        "completion_date": [
          "January 2020"
        ],
        "last_verified": [
          "March 2017"
        ],
        "first_received": [
          "November 23, 2015"
        ],
        "last_updated": [
          "March 30, 2017"
        ],
        "study_first_submitted": [
          "November 23, 2015"
        ],
        "study_first_posted": [
          "December 3, 2015"
        ],
        "last_update_submitted": [
          "March 30, 2017"
        ],
        "last_update_posted": [
          "April 4, 2017"
        ],
        "locations": [
          {
            "location": [
              "University of Hawaii, John A Burns School of Medicine, Department of Native Hawaiian Health, Honolulu, Hawaii, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02620709"
        ]
      },
      {
        "$": {
          "rank": "83"
        },
        "nct_id": [
          "NCT02961517"
        ],
        "title": [
          "Format of Patient Education for Different Sociodemographic Groups"
        ],
        "recruitment": [
          {
            "_": "Not yet recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Type2 Diabetes Mellitus",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Questionnaire",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Effect of sociodemographic characteristics",
              "Reasons for preferences",
              "Preference for online"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Leicester"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "200"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Time Perspective: Cross-Sectional"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "0594"
            ]
          }
        ],
        "start_date": [
          "December 2016"
        ],
        "primary_completion_date": [
          "September 2017"
        ],
        "completion_date": [
          "September 2017"
        ],
        "last_verified": [
          "November 2016"
        ],
        "first_received": [
          "November 8, 2016"
        ],
        "last_updated": [
          "November 8, 2016"
        ],
        "study_first_submitted": [
          "November 8, 2016"
        ],
        "study_first_posted": [
          "November 11, 2016"
        ],
        "last_update_submitted": [
          "November 8, 2016"
        ],
        "last_update_posted": [
          "November 11, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02961517"
        ]
      },
      {
        "$": {
          "rank": "84"
        },
        "nct_id": [
          "NCT02353663"
        ],
        "title": [
          "Rheumatic Heart Disease in Peru: Prevalence and Cardiovascular Outcomes Among Schoolchildren"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Rheumatic Heart Disease",
              "Acute Rheumatic Fever"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Echocardiography",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Rheumatic heart disease according to WHO and WHF criteria",
              "Progression of disease"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University Hospital Inselspital, Berne"
            ],
            "collaborator": [
              "Instituto de Cardiología Paredes-Horna, Arequipa",
              "EsSalud National Hospital Carlos Alberto Seguin Escobedo"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "5 Years"
        ],
        "max_age": [
          "16 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "1023"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Cross-Sectional"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "1927-CIEI_USMP-CCM"
            ]
          }
        ],
        "start_date": [
          "April 2014"
        ],
        "primary_completion_date": [
          "December 2014"
        ],
        "completion_date": [
          "July 2015"
        ],
        "last_verified": [
          "April 2016"
        ],
        "first_received": [
          "January 28, 2015"
        ],
        "last_updated": [
          "April 5, 2016"
        ],
        "study_first_submitted": [
          "January 28, 2015"
        ],
        "study_first_posted": [
          "February 3, 2015"
        ],
        "last_update_submitted": [
          "April 5, 2016"
        ],
        "last_update_posted": [
          "April 6, 2016"
        ],
        "locations": [
          {
            "location": [
              "Instituto de Cardiología Paredes-Horna, Arequipa, Peru",
              "Department of Cardiology, Bern, Switzerland"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02353663"
        ]
      },
      {
        "$": {
          "rank": "85"
        },
        "nct_id": [
          "NCT02789722"
        ],
        "title": [
          "Yerba Mate (Ilex Paraguariensis A.St.-Hil.): Assessment of Cardiovascular Health"
        ],
        "acronym": [
          "YMCH-2015"
        ],
        "recruitment": [
          {
            "_": "Enrolling by invitation",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Diabetes"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Yerba Mate Extract",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Placebo",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Quantification of biochemical parameters: total cholesterol and fractions, triglycerides and fasting glucose.",
              "Quantification of inflammatory markers: C-reactive protein.",
              "Quantification of adhesion molecule:Endothelin, Intercellular adhesion molecule (ICAM-1) and vascular endothelial cell adhesion molecule (VCAM-1).",
              "Quantification of inflammatory markers: Interleukin-6.",
              "Evaluation of the tolerance glucose.",
              "Evaluation of transcriptome analysis.",
              "Clinical evaluation: arterial pressure (mean of three measurements for each 5 minutes).",
              "Clinical evaluation: waist circumference.",
              "Clinical evaluation: pulse.",
              "Clinical evaluation: weight."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Karimi Sater Gebara"
            ],
            "collaborator": [
              "Institut National de la Recherche Agronomique",
              "Universidade Paranaense"
            ]
          }
        ],
        "gender": [
          "Male"
        ],
        "min_age": [
          "45 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "36"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Triple (Participant, Care Provider, Investigator)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "UNP-ILCV-1518"
            ]
          }
        ],
        "start_date": [
          "June 2016"
        ],
        "primary_completion_date": [
          "June 2017"
        ],
        "completion_date": [
          "December 2018"
        ],
        "last_verified": [
          "May 2016"
        ],
        "first_received": [
          "February 28, 2016"
        ],
        "last_updated": [
          "May 27, 2016"
        ],
        "study_first_submitted": [
          "February 28, 2016"
        ],
        "study_first_posted": [
          "June 3, 2016"
        ],
        "last_update_submitted": [
          "May 27, 2016"
        ],
        "last_update_posted": [
          "June 3, 2016"
        ],
        "locations": [
          {
            "location": [
              "Euclides Lara Cardozo Júnior, Toledo, Paraná, Brazil"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02789722"
        ]
      },
      {
        "$": {
          "rank": "86"
        },
        "nct_id": [
          "NCT02767739"
        ],
        "title": [
          "Effects of Physical Activity on Cardiovascular Risk and Quality of Life"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases",
              "Quality of Life"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Physical, social and cultural activities",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Physical activity level",
              "Cardiovascular risk.",
              "Biochemical analysis.",
              "Antropometric measurements.",
              "Frequency of food consumption",
              "Health related quality of life"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University Rovira i Virgili"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "70 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "419"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "P11/67"
            ]
          }
        ],
        "start_date": [
          "September 2011"
        ],
        "primary_completion_date": [
          "December 2011"
        ],
        "completion_date": [
          "July 2015"
        ],
        "last_verified": [
          "May 2016"
        ],
        "first_received": [
          "May 4, 2016"
        ],
        "last_updated": [
          "May 5, 2016"
        ],
        "study_first_submitted": [
          "May 4, 2016"
        ],
        "study_first_posted": [
          "May 10, 2016"
        ],
        "last_update_submitted": [
          "May 5, 2016"
        ],
        "last_update_posted": [
          "May 10, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02767739"
        ]
      },
      {
        "$": {
          "rank": "87"
        },
        "nct_id": [
          "NCT02536456"
        ],
        "title": [
          "China PEACE Millions Persons Project"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Incidence of Cardiovascular diseases"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "China National Center for Cardiovascular Diseases"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "35 Years"
        ],
        "max_age": [
          "75 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "4000000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "20150823"
            ]
          }
        ],
        "start_date": [
          "July 2014"
        ],
        "primary_completion_date": [
          "July 2020"
        ],
        "completion_date": [
          "July 2020"
        ],
        "last_verified": [
          "July 2016"
        ],
        "first_received": [
          "August 24, 2015"
        ],
        "last_updated": [
          "July 21, 2016"
        ],
        "study_first_submitted": [
          "August 24, 2015"
        ],
        "study_first_posted": [
          "August 31, 2015"
        ],
        "last_update_submitted": [
          "July 21, 2016"
        ],
        "last_update_posted": [
          "July 25, 2016"
        ],
        "locations": [
          {
            "location": [
              "Fuwai hospital, Beijing, Beijing, China"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02536456"
        ]
      },
      {
        "$": {
          "rank": "88"
        },
        "nct_id": [
          "NCT02872974"
        ],
        "title": [
          "Gestational Diabetes and Offspring's Cardiovascular Health: MySweetHeart Cohort"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases",
              "Gestational Diabetes Mellitus"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "GDM",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Left ventricular mass index",
              "Carotid intima-media thickness",
              "Fetal cardiovascular alterations",
              "Fetal left ventricular mass index",
              "Fetal liver volume",
              "Cardiovascular risk factors"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Lausanne Hospitals"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "age_groups": [
          {
            "age_group": [
              "Child",
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "200"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "2016-00745-C"
            ]
          }
        ],
        "start_date": [
          "August 2016"
        ],
        "primary_completion_date": [
          "August 2019"
        ],
        "completion_date": [
          "August 2020"
        ],
        "last_verified": [
          "September 2016"
        ],
        "first_received": [
          "August 16, 2016"
        ],
        "last_updated": [
          "September 19, 2016"
        ],
        "study_first_submitted": [
          "August 16, 2016"
        ],
        "study_first_posted": [
          "August 19, 2016"
        ],
        "last_update_submitted": [
          "September 19, 2016"
        ],
        "last_update_posted": [
          "September 20, 2016"
        ],
        "locations": [
          {
            "location": [
              "Lausanne University Hospital, Lausanne, Vaud, Switzerland"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02872974"
        ]
      },
      {
        "$": {
          "rank": "89"
        },
        "nct_id": [
          "NCT02641197"
        ],
        "title": [
          "Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "AngioDefender",
                "$": {
                  "type": "Device"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change from baseline %flow-mediation dilation (%FMD) at 1 hour",
              "Reproducibility of multiple %FMD determinations by AngioDefender",
              "Incidence of emergent adverse device effects (ADEs) according to CTCAE v4.03"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Everist Genomics, Inc"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "40"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Diagnostic"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "A-1501"
            ]
          }
        ],
        "start_date": [
          "April 2016"
        ],
        "primary_completion_date": [
          "March 2017"
        ],
        "completion_date": [
          "March 2017"
        ],
        "last_verified": [
          "February 2017"
        ],
        "first_received": [
          "December 16, 2015"
        ],
        "last_updated": [
          "February 6, 2017"
        ],
        "study_first_submitted": [
          "December 16, 2015"
        ],
        "study_first_posted": [
          "December 29, 2015"
        ],
        "last_update_submitted": [
          "February 6, 2017"
        ],
        "last_update_posted": [
          "February 8, 2017"
        ],
        "locations": [
          {
            "location": [
              "University of Western Ontario, London, Ontario, Canada",
              "Hotel-Dieu Grace Healthcare, Windsor, Ontario, Canada"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02641197"
        ]
      },
      {
        "$": {
          "rank": "90"
        },
        "nct_id": [
          "NCT02740699"
        ],
        "title": [
          "CT COMPARE: CT COronary Angiography to Measure PlAque REduction"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Rosuvastatin",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Atorvastatin",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "To prospectively compare the change in coronary artery plaque burden determined by CCTA in asymptomatic individuals with moderate CVD risk treated either a) according to 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athe..."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "National Heart, Lung, and Blood Institute (NHLBI)"
            ],
            "collaborator": [
              "National Institutes of Health Clinical Center (CC)"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "45 Years"
        ],
        "max_age": [
          "75 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 4"
            ]
          }
        ],
        "enrollment": [
          "190"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "NIH"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "160089",
              "16-H-0089"
            ]
          }
        ],
        "start_date": [
          "April 14, 2016"
        ],
        "primary_completion_date": [
          "December 15, 2020"
        ],
        "completion_date": [
          "December 15, 2020"
        ],
        "last_verified": [
          "August 10, 2017"
        ],
        "first_received": [
          "April 14, 2016"
        ],
        "last_updated": [
          "October 18, 2017"
        ],
        "study_first_submitted": [
          "April 14, 2016"
        ],
        "study_first_posted": [
          "April 15, 2016"
        ],
        "last_update_submitted": [
          "October 18, 2017"
        ],
        "last_update_posted": [
          "October 19, 2017"
        ],
        "locations": [
          {
            "location": [
              "National Institutes of Health Clinical Center, Bethesda, Maryland, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02740699"
        ]
      },
      {
        "$": {
          "rank": "91"
        },
        "nct_id": [
          "NCT02866448"
        ],
        "title": [
          "Impact of isoQUercetin and Aspirin on Platelet Function"
        ],
        "acronym": [
          "QUAP"
        ],
        "recruitment": [
          {
            "_": "Withdrawn",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Vehicle control",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Isoquercetin",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Aspirin",
                "$": {
                  "type": "Drug"
                }
              },
              {
                "_": "Isoquercetin plus Aspirin",
                "$": {
                  "type": "Drug"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change from baseline in platelet aggregation",
              "Change from baseline in Closure Time (CT), measured with a Platelet Function Analyzer (PFA)",
              "Change from baseline in blood pressure (systolic pressure, diastolic pressure and pulse pressure)",
              "Change from baseline in arterial stiffness measured by digital volume pulse - stiffness index",
              "Change from baseline in arterial stiffness measured by digital volume pulse - reflection index",
              "Change from baseline in total plasma quercetin concentration (micromolar)",
              "Change from baseline in total urine quercetin concentration (micromolar)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Reading"
            ],
            "collaborator": [
              "Biotechnology and Biological Sciences Research Council",
              "Quercegen Pharmaceuticals"
            ]
          }
        ],
        "gender": [
          "Male"
        ],
        "min_age": [
          "18 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "0"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Triple (Participant, Investigator, Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "16/38"
            ]
          }
        ],
        "start_date": [
          "August 2016"
        ],
        "primary_completion_date": [
          "October 2016"
        ],
        "completion_date": [
          "October 2016"
        ],
        "last_verified": [
          "November 2016"
        ],
        "first_received": [
          "August 2, 2016"
        ],
        "last_updated": [
          "November 28, 2016"
        ],
        "study_first_submitted": [
          "August 2, 2016"
        ],
        "study_first_posted": [
          "August 15, 2016"
        ],
        "last_update_submitted": [
          "November 28, 2016"
        ],
        "last_update_posted": [
          "November 29, 2016"
        ],
        "locations": [
          {
            "location": [
              "University of Reading, Reading, Berkshire, United Kingdom"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02866448"
        ]
      },
      {
        "$": {
          "rank": "92"
        },
        "nct_id": [
          "NCT02888886"
        ],
        "title": [
          "Role of Systemic Inflammation in Increase of Cardio-vascular Risk in Chronic Obstructive Pulmonary Disease"
        ],
        "acronym": [
          "BPCO"
        ],
        "recruitment": [
          {
            "_": "Completed",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Chronic Obstructive Pulmonary Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Questionnaires about food habits and tobacco",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Spirometry",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Carotid echography",
                "$": {
                  "type": "Other"
                }
              },
              {
                "_": "Blood sample",
                "$": {
                  "type": "Other"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Mortality"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Central Hospital, Nancy, France"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "75 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "89"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Intervention Model: Single Group Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "2006-A00053-48"
            ]
          }
        ],
        "start_date": [
          "July 2007"
        ],
        "primary_completion_date": [
          "November 2015"
        ],
        "completion_date": [
          "November 2015"
        ],
        "last_verified": [
          "August 2016"
        ],
        "first_received": [
          "August 31, 2016"
        ],
        "last_updated": [
          "August 31, 2016"
        ],
        "study_first_submitted": [
          "August 31, 2016"
        ],
        "study_first_posted": [
          "September 5, 2016"
        ],
        "last_update_submitted": [
          "August 31, 2016"
        ],
        "last_update_posted": [
          "September 5, 2016"
        ],
        "locations": [
          ""
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02888886"
        ]
      },
      {
        "$": {
          "rank": "93"
        },
        "nct_id": [
          "NCT02871934"
        ],
        "title": [
          "Integrating Pharmacogenetics In Clinical Care"
        ],
        "acronym": [
          "IPICC"
        ],
        "recruitment": [
          {
            "_": "Enrolling by invitation",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "SLCO1B1 Genotype",
                "$": {
                  "type": "Genetic"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "LDL cholesterol",
              "Concordance with American College of Cardiology/American Heart Association (ACC/AHA) guidelines for statin use in CVD prevention",
              "Documentation of statin-related myotoxicity",
              "Concordance with CPIC guidelines for simvastatin use"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "VA Office of Research and Development"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "75 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "408"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "U.S. Fed"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: Double (Participant, Care Provider)",
              "Primary Purpose: Diagnostic"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "SPLC-006-15S",
              "IK2CX001262"
            ]
          }
        ],
        "start_date": [
          "August 1, 2016"
        ],
        "primary_completion_date": [
          "December 31, 2020"
        ],
        "completion_date": [
          "December 31, 2020"
        ],
        "last_verified": [
          "September 2017"
        ],
        "first_received": [
          "August 16, 2016"
        ],
        "last_updated": [
          "September 8, 2017"
        ],
        "study_first_submitted": [
          "August 16, 2016"
        ],
        "study_first_posted": [
          "August 18, 2016"
        ],
        "last_update_submitted": [
          "September 8, 2017"
        ],
        "last_update_posted": [
          "September 11, 2017"
        ],
        "locations": [
          {
            "location": [
              "VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02871934"
        ]
      },
      {
        "$": {
          "rank": "94"
        },
        "nct_id": [
          "NCT02616510"
        ],
        "title": [
          "Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile"
        ],
        "acronym": [
          "POPCORn"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "cardiovascular screening",
                "$": {
                  "type": "Procedure"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "carotid intima media thickness",
              "dyslipidemia",
              "insulin and glucose levels",
              "C-reactive protein",
              "homocysteine",
              "uric acid",
              "androgen levels",
              "electrocardiogram (ECG)",
              "cardiac ultrasound (hypertrophy)"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "UMC Utrecht"
            ],
            "collaborator": [
              "VU University Medical Center",
              "Erasmus Medical Center"
            ]
          }
        ],
        "gender": [
          "Female"
        ],
        "min_age": [
          "45 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "125"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Case-Control",
              "Time Perspective: Cross-Sectional"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "13-010"
            ]
          }
        ],
        "start_date": [
          "July 2013"
        ],
        "primary_completion_date": [
          "December 2017"
        ],
        "completion_date": [
          "December 2017"
        ],
        "last_verified": [
          "May 2017"
        ],
        "first_received": [
          "November 20, 2015"
        ],
        "last_updated": [
          "May 15, 2017"
        ],
        "study_first_submitted": [
          "November 20, 2015"
        ],
        "study_first_posted": [
          "November 30, 2015"
        ],
        "last_update_submitted": [
          "May 15, 2017"
        ],
        "last_update_posted": [
          "May 16, 2017"
        ],
        "locations": [
          {
            "location": [
              "University Medical Center Utrecht, Utrecht, Netherlands"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02616510"
        ]
      },
      {
        "$": {
          "rank": "95"
        },
        "nct_id": [
          "NCT02422745"
        ],
        "title": [
          "COcoa Supplement and Multivitamin Outcomes Study"
        ],
        "acronym": [
          "COSMOS"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Cardiovascular Disease",
              "Cancer"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Cocoa extract",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Multivitamin",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Cocoa extract placebo",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Multivitamin placebo",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "The total number of cases of cardiovascular disease (CVD) events.",
              "The total number of cases of invasive cancer"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "Brigham and Women's Hospital"
            ],
            "collaborator": [
              "Fred Hutchinson Cancer Research Center",
              "Mars, Inc.",
              "Pfizer"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "60 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 4"
            ]
          }
        ],
        "enrollment": [
          "18000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other",
              "Industry"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Factorial Assignment",
              "Masking: Double (Participant, Investigator)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "2014D001652"
            ]
          }
        ],
        "start_date": [
          "June 2015"
        ],
        "primary_completion_date": [
          "March 2020"
        ],
        "completion_date": [
          "October 2020"
        ],
        "last_verified": [
          "July 2017"
        ],
        "first_received": [
          "April 17, 2015"
        ],
        "last_updated": [
          "July 12, 2017"
        ],
        "study_first_submitted": [
          "April 17, 2015"
        ],
        "study_first_posted": [
          "April 21, 2015"
        ],
        "last_update_submitted": [
          "July 12, 2017"
        ],
        "last_update_posted": [
          "July 13, 2017"
        ],
        "locations": [
          {
            "location": [
              "Brigham and Women's Hospital, Boston, Massachusetts, United States",
              "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02422745"
        ]
      },
      {
        "$": {
          "rank": "96"
        },
        "nct_id": [
          "NCT02485626"
        ],
        "title": [
          "Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors"
        ],
        "acronym": [
          "HARBOR"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Breast Neoplasms",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "2D tissue doppler echocardiography",
                "$": {
                  "type": "Procedure"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Left ventricular ejection fraction",
              "Diastolic cardiac function",
              "Cardiac deformation",
              "Biomarker assessment",
              "Intima media thickness and arterial stiffness"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "The Netherlands Cancer Institute"
            ],
            "collaborator": [
              "University Medical Center Groningen"
            ]
          }
        ],
        "gender": [
          "Female"
        ],
        "min_age": [
          "40 Years"
        ],
        "max_age": [
          "50 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "628"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Cross-Sectional"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "NL49405.031.14"
            ]
          }
        ],
        "start_date": [
          "April 2015"
        ],
        "primary_completion_date": [
          "April 2019"
        ],
        "completion_date": [
          "December 2019"
        ],
        "last_verified": [
          "October 2016"
        ],
        "first_received": [
          "June 23, 2015"
        ],
        "last_updated": [
          "October 28, 2016"
        ],
        "study_first_submitted": [
          "June 23, 2015"
        ],
        "study_first_posted": [
          "June 30, 2015"
        ],
        "last_update_submitted": [
          "October 28, 2016"
        ],
        "last_update_posted": [
          "October 31, 2016"
        ],
        "locations": [
          {
            "location": [
              "NKI-AVL, Amsterdam, Netherlands",
              "UMCG, Groningen, Netherlands"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02485626"
        ]
      },
      {
        "$": {
          "rank": "97"
        },
        "nct_id": [
          "NCT02541435"
        ],
        "title": [
          "Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Breast Neoplasms",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "incidence of cardiovascular disease"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "St. Olavs Hospital"
            ],
            "collaborator": [
              "Norwegian University of Science and Technology",
              "Alesund Hospital"
            ]
          }
        ],
        "gender": [
          "Female"
        ],
        "min_age": [
          "30 Years"
        ],
        "max_age": [
          "70 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "1600"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Cohort",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "2015/583"
            ]
          }
        ],
        "start_date": [
          "November 2016"
        ],
        "primary_completion_date": [
          "December 2033"
        ],
        "completion_date": [
          "December 2033"
        ],
        "last_verified": [
          "November 2016"
        ],
        "first_received": [
          "September 1, 2015"
        ],
        "last_updated": [
          "November 3, 2016"
        ],
        "study_first_submitted": [
          "September 1, 2015"
        ],
        "study_first_posted": [
          "September 4, 2015"
        ],
        "last_update_submitted": [
          "November 3, 2016"
        ],
        "last_update_posted": [
          "November 4, 2016"
        ],
        "locations": [
          {
            "location": [
              "St Olavs University Hospital, Trondheim, Norway",
              "Ålesund Hospital, Ålesund, Norway"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02541435"
        ]
      },
      {
        "$": {
          "rank": "98"
        },
        "nct_id": [
          "NCT02535910"
        ],
        "title": [
          "Effect of vitaminD3 or 25(OH)D3 Fortified Dairy on Vitmain D Status and CVD Risk Markers"
        ],
        "recruitment": [
          {
            "_": "Unknown status",
            "$": {
              "open": "N"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Hypovitaminosis D",
              "Cardiovascular Diseases"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "vitamin D3",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "25(OH) D3",
                "$": {
                  "type": "Dietary Supplement"
                }
              },
              {
                "_": "Control",
                "$": {
                  "type": "Dietary Supplement"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Change from baseline in the concentrations of vitamin D3, 25(OH)D3, 1, 25(OH)2D3 of the blood",
              "Change from baseline in the concentrations of vitamin D3 and 25(OH)D3 of the chylomicron",
              "change from baseline in vascular reactivity measured by Endo-PAT",
              "change from baseline in vascular reactivity measured by digital volume pulse (DVP)",
              "change from baseline in plasma lipids (primarily triacylglycerol, apolipoprotein B, apolipoprotein B-48, apolipoprotien B-100, total-cholesterol, HDL-cholesterol, non-esterified fatty acids)",
              "change from baseline in markers of insulin resistance (glucose and insulin)",
              "change from baseline in nitric oxide",
              "change from baseline in inflammatory markers (tumor necrosis factor alpha, C-reactive protein and interleukin 6) of the blood",
              "change from baseline in blood pressure",
              "change from baseline in cognitive test"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University of Reading"
            ]
          }
        ],
        "gender": [
          "Male"
        ],
        "min_age": [
          "30 Years"
        ],
        "max_age": [
          "65 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "18"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Crossover Assignment",
              "Masking: Triple (Participant, Investigator, Outcomes Assessor)",
              "Primary Purpose: Prevention"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "VitD"
            ]
          }
        ],
        "start_date": [
          "August 2015"
        ],
        "primary_completion_date": [
          "December 2015"
        ],
        "completion_date": [
          "May 2016"
        ],
        "last_verified": [
          "September 2015"
        ],
        "first_received": [
          "July 28, 2015"
        ],
        "last_updated": [
          "September 23, 2015"
        ],
        "study_first_submitted": [
          "July 28, 2015"
        ],
        "study_first_posted": [
          "August 31, 2015"
        ],
        "last_update_submitted": [
          "September 23, 2015"
        ],
        "last_update_posted": [
          "September 24, 2015"
        ],
        "locations": [
          {
            "location": [
              "Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading, Reading, Berkshire, United Kingdom"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02535910"
        ]
      },
      {
        "$": {
          "rank": "99"
        },
        "nct_id": [
          "NCT02938832"
        ],
        "title": [
          "Does the Advice to Eat a Mediterranean Diet With Low Carbohydrate Intake, Compared With a Low-fat Diet, Reduce Diabetes and Cardiovascular Disease?"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Ischemic Heart Disease"
            ]
          }
        ],
        "interventions": [
          {
            "intervention": [
              {
                "_": "Advice on what food to choose and eat",
                "$": {
                  "type": "Behavioral"
                }
              }
            ]
          }
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Diabetes incidence",
              "Cardiovascular disease",
              "Quality of Life"
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "University Hospital, Linkoeping"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "18 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          {
            "phase": [
              "Phase 4"
            ]
          }
        ],
        "enrollment": [
          "1200"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Interventional"
        ],
        "study_designs": [
          {
            "study_design": [
              "Allocation: Randomized",
              "Intervention Model: Parallel Assignment",
              "Masking: None (Open Label)",
              "Primary Purpose: Treatment"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "CardioDiet"
            ]
          }
        ],
        "start_date": [
          "October 2016"
        ],
        "primary_completion_date": [
          "October 2020"
        ],
        "completion_date": [
          "October 2023"
        ],
        "last_verified": [
          "October 2016"
        ],
        "first_received": [
          "October 17, 2016"
        ],
        "last_updated": [
          "October 19, 2016"
        ],
        "study_first_submitted": [
          "October 17, 2016"
        ],
        "study_first_posted": [
          "October 19, 2016"
        ],
        "last_update_submitted": [
          "October 19, 2016"
        ],
        "last_update_posted": [
          "October 21, 2016"
        ],
        "locations": [
          {
            "location": [
              "University Hospital of Linkoping, Linkoping, Sweden"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02938832"
        ]
      },
      {
        "$": {
          "rank": "100"
        },
        "nct_id": [
          "NCT02814396"
        ],
        "title": [
          "The Application of Multichannel ECG Analytic System in Cardiovascular Diseases"
        ],
        "recruitment": [
          {
            "_": "Recruiting",
            "$": {
              "open": "Y"
            }
          }
        ],
        "study_results": [
          "No Results Available"
        ],
        "conditions": [
          {
            "condition": [
              "Multichannel ECG System"
            ]
          }
        ],
        "interventions": [
          ""
        ],
        "outcome_measures": [
          {
            "outcome_measure": [
              "Composite cardiovascular outcome",
              "With at least 1 cardiovascular risk factor."
            ]
          }
        ],
        "sponsors": [
          {
            "lead_sponsor": [
              "National Taiwan University Hospital"
            ]
          }
        ],
        "gender": [
          "All"
        ],
        "min_age": [
          "20 Years"
        ],
        "age_groups": [
          {
            "age_group": [
              "Adult",
              "Senior"
            ]
          }
        ],
        "phases": [
          ""
        ],
        "enrollment": [
          "5000"
        ],
        "funded_bys": [
          {
            "funded_by": [
              "Other"
            ]
          }
        ],
        "study_types": [
          "Observational"
        ],
        "study_designs": [
          {
            "study_design": [
              "Observational Model: Case-Only",
              "Time Perspective: Prospective"
            ]
          }
        ],
        "other_ids": [
          {
            "other_id": [
              "201207070RIC"
            ]
          }
        ],
        "start_date": [
          "January 2013"
        ],
        "primary_completion_date": [
          "October 2018"
        ],
        "completion_date": [
          "October 2018"
        ],
        "last_verified": [
          "January 2017"
        ],
        "first_received": [
          "June 23, 2016"
        ],
        "last_updated": [
          "January 16, 2017"
        ],
        "study_first_submitted": [
          "June 23, 2016"
        ],
        "study_first_posted": [
          "June 27, 2016"
        ],
        "last_update_submitted": [
          "January 16, 2017"
        ],
        "last_update_posted": [
          "January 18, 2017"
        ],
        "locations": [
          {
            "location": [
              "NTUH, Taipei, Taiwan"
            ]
          }
        ],
        "url": [
          "https://ClinicalTrials.gov/show/NCT02814396"
        ]
      }
    ]
  }
}
